id	sid	tid	token	lemma	pos
iajs-801	1	1	ibn	ibn	PROPN
iajs-801	1	2	alhaitham	alhaitham	NOUN
iajs-801	1	3	j.	j.	PROPN
iajs-801	1	4	for	for	ADP
iajs-801	1	5	pure	pure	ADJ
iajs-801	1	6	&	&	CCONJ
iajs-801	1	7	appl	appl	PROPN
iajs-801	1	8	.	.	PUNCT
iajs-801	2	1	sci	sci	PROPN
iajs-801	2	2	.	.	PUNCT
iajs-801	2	3	vol.24	vol.24	NOUN
iajs-801	2	4	(	(	PUNCT
iajs-801	2	5	1	1	NUM
iajs-801	2	6	)	)	PUNCT
iajs-801	2	7	2011	2011	NUM
iajs-801	2	8	evaluation	evaluation	NOUN
iajs-801	2	9	of	of	ADP
iajs-801	2	10	α1	α1	PROPN
iajs-801	2	11	-	-	PUNCT
iajs-801	2	12	antitrypsine	antitrypsine	NOUN
iajs-801	2	13	and	and	CCONJ
iajs-801	2	14	reduced	reduce	VERB
iajs-801	2	15	glutathione	glutathione	NOUN
iajs-801	2	16	in	in	ADP
iajs-801	2	17	iraqi	iraqi	ADJ
iajs-801	2	18	patients	patient	NOUN
iajs-801	2	19	of	of	ADP
iajs-801	2	20	diabetes	diabetes	NOUN
iajs-801	2	21	mellitus	mellitus	PROPN
iajs-801	2	22	type	type	PROPN
iajs-801	2	23	ii	ii	PROPN
iajs-801	2	24	.	.	PROPN
iajs-801	2	25	received	receive	VERB
iajs-801	2	26	in	in	ADP
iajs-801	2	27	:	:	PUNCT
iajs-801	2	28	may	may	AUX
iajs-801	2	29	,	,	PUNCT
iajs-801	2	30	9	9	NUM
iajs-801	2	31	,	,	PUNCT
iajs-801	2	32	2010	2010	NUM
iajs-801	2	33	accepted	accept	VERB
iajs-801	2	34	in	in	ADP
iajs-801	2	35	:	:	PUNCT
iajs-801	2	36	june	june	PROPN
iajs-801	2	37	,	,	PUNCT
iajs-801	2	38	30	30	NUM
iajs-801	2	39	,	,	PUNCT
iajs-801	2	40	2010	2010	NUM
iajs-801	2	41	a.	a.	NOUN
iajs-801	2	42	f.	f.	PROPN
iajs-801	2	43	al	al	PROPN
iajs-801	2	44	-	-	PUNCT
iajs-801	2	45	tai	tai	PROPN
iajs-801	2	46	,	,	PUNCT
iajs-801	2	47	,	,	PUNCT
iajs-801	2	48	*	*	PUNCT
iajs-801	2	49	y.	y.	PROPN
iajs-801	2	50	y.	y.	PROPN
iajs-801	2	51	z.	z.	PROPN
iajs-801	2	52	farid	farid	PROPN
iajs-801	2	53	and	and	CCONJ
iajs-801	2	54	w.f	w.f	PROPN
iajs-801	2	55	.	.	PROPN
iajs-801	2	56	altai	altai	PROPN
iajs-801	2	57	department	department	PROPN
iajs-801	2	58	of	of	ADP
iajs-801	2	59	chemistry	chemistry	PROPN
iajs-801	2	60	,	,	PUNCT
iajs-801	2	61	college	college	NOUN
iajs-801	2	62	of	of	ADP
iajs-801	2	63	education	education	PROPN
iajs-801	2	64	ibn	ibn	PROPN
iajs-801	2	65	al	al	PROPN
iajs-801	2	66	-	-	PUNCT
iajs-801	2	67	haitham	haitham	PROPN
iajs-801	2	68	,	,	PUNCT
iajs-801	2	69	university	university	NOUN
iajs-801	2	70	of	of	ADP
iajs-801	2	71	baghdad	baghdad	PROPN
iajs-801	2	72	*	*	PUNCT
iajs-801	2	73	college	college	PROPN
iajs-801	2	74	of	of	ADP
iajs-801	2	75	medicine	medicine	PROPN
iajs-801	2	76	al	al	PROPN
iajs-801	2	77	-	-	PUNCT
iajs-801	2	78	nahrain	nahrain	PROPN
iajs-801	2	79	,	,	PUNCT
iajs-801	2	80	university	university	NOUN
iajs-801	2	81	of	of	ADP
iajs-801	2	82	al	al	PROPN
iajs-801	2	83	-	-	PUNCT
iajs-801	2	84	nahrain	nahrain	PROPN
iajs-801	2	85	abstract	abstract	NOUN
iajs-801	2	86	in	in	ADP
iajs-801	2	87	order	order	NOUN
iajs-801	2	88	to	to	PART
iajs-801	2	89	investigate	investigate	VERB
iajs-801	2	90	the	the	DET
iajs-801	2	91	levels	level	NOUN
iajs-801	2	92	of	of	ADP
iajs-801	2	93	reduced	reduced	ADJ
iajs-801	2	94	glutathione	glutathione	NOUN
iajs-801	2	95	gsh	gsh	NOUN
iajs-801	2	96	and	and	CCONJ
iajs-801	2	97	α1	α1	PROPN
iajs-801	2	98	-	-	PUNCT
iajs-801	2	99	antitrypsine	antitrypsine	NOUN
iajs-801	2	100	in	in	ADP
iajs-801	2	101	the	the	DET
iajs-801	2	102	sera	sera	NOUN
iajs-801	2	103	of	of	ADP
iajs-801	2	104	20	20	NUM
iajs-801	2	105	type	type	NOUN
iajs-801	2	106	2	2	NUM
iajs-801	2	107	diabetic	diabetic	ADJ
iajs-801	2	108	patients	patient	NOUN
iajs-801	2	109	and	and	CCONJ
iajs-801	2	110	10	10	NUM
iajs-801	2	111	healthy	healthy	ADJ
iajs-801	2	112	subjects	subject	NOUN
iajs-801	2	113	,	,	PUNCT
iajs-801	2	114	were	be	AUX
iajs-801	2	115	enrolled	enrol	VERB
iajs-801	2	116	in	in	ADP
iajs-801	2	117	this	this	DET
iajs-801	2	118	study	study	NOUN
iajs-801	2	119	.	.	PUNCT
iajs-801	3	1	a	a	DET
iajs-801	3	2	significant	significant	ADJ
iajs-801	3	3	reduction	reduction	NOUN
iajs-801	3	4	in	in	ADP
iajs-801	3	5	gsh	gsh	PROPN
iajs-801	3	6	level	level	NOUN
iajs-801	3	7	was	be	AUX
iajs-801	3	8	found	find	VERB
iajs-801	3	9	in	in	ADP
iajs-801	3	10	the	the	DET
iajs-801	3	11	patient	patient	NOUN
iajs-801	3	12	group	group	NOUN
iajs-801	3	13	compared	compare	VERB
iajs-801	3	14	with	with	ADP
iajs-801	3	15	control	control	NOUN
iajs-801	3	16	.	.	PUNCT
iajs-801	4	1	on	on	ADP
iajs-801	4	2	the	the	DET
iajs-801	4	3	other	other	ADJ
iajs-801	4	4	hand	hand	NOUN
iajs-801	4	5	a	a	DET
iajs-801	4	6	significant	significant	ADJ
iajs-801	4	7	elevation	elevation	NOUN
iajs-801	4	8	in	in	ADP
iajs-801	4	9	α1	α1	PROPN
iajs-801	4	10	-	-	PUNCT
iajs-801	4	11	antitrypsine	antitrypsine	NOUN
iajs-801	4	12	in	in	ADP
iajs-801	4	13	patient	patient	NOUN
iajs-801	4	14	compared	compare	VERB
iajs-801	4	15	with	with	ADP
iajs-801	4	16	control	control	NOUN
iajs-801	4	17	was	be	AUX
iajs-801	4	18	observed	observe	VERB
iajs-801	4	19	.	.	PUNCT
iajs-801	5	1	correlation	correlation	NOUN
iajs-801	5	2	between	between	ADP
iajs-801	5	3	α1	α1	PROPN
iajs-801	5	4	-	-	PUNCT
iajs-801	5	5	antitrypsine	antitrypsine	NOUN
iajs-801	5	6	and	and	CCONJ
iajs-801	5	7	reduced	reduce	VERB
iajs-801	5	8	glutathion	glutathion	NOUN
iajs-801	5	9	was	be	AUX
iajs-801	5	10	found	find	VERB
iajs-801	5	11	to	to	PART
iajs-801	5	12	be	be	AUX
iajs-801	5	13	positive	positive	ADJ
iajs-801	5	14	(	(	PUNCT
iajs-801	5	15	+	+	NOUN
iajs-801	5	16	ve	ve	VERB
iajs-801	5	17	)	)	PUNCT
iajs-801	5	18	for	for	ADP
iajs-801	5	19	diabetes	diabetes	NOUN
iajs-801	5	20	mellitus	mellitus	PROPN
iajs-801	5	21	type2	type2	PROPN
iajs-801	5	22	patients	patient	NOUN
iajs-801	5	23	and	and	CCONJ
iajs-801	5	24	negative	negative	ADJ
iajs-801	5	25	(	(	PUNCT
iajs-801	5	26	-ve	-ve	NOUN
iajs-801	5	27	)	)	PUNCT
iajs-801	5	28	for	for	ADP
iajs-801	5	29	healthy	healthy	ADJ
iajs-801	5	30	control	control	NOUN
iajs-801	5	31	with	with	ADP
iajs-801	5	32	r	r	NOUN
iajs-801	5	33	values	value	NOUN
iajs-801	5	34	0.257	0.257	NUM
iajs-801	5	35	and	and	CCONJ
iajs-801	5	36	–	–	PUNCT
iajs-801	5	37	0.339	0.339	NUM
iajs-801	5	38	respectively	respectively	ADV
iajs-801	5	39	.	.	PUNCT
iajs-801	6	1	in	in	ADP
iajs-801	6	2	conclusion	conclusion	NOUN
iajs-801	6	3	the	the	DET
iajs-801	6	4	depletion	depletion	NOUN
iajs-801	6	5	of	of	ADP
iajs-801	6	6	gsh	gsh	NOUN
iajs-801	6	7	as	as	ADP
iajs-801	6	8	antioxidant	antioxidant	ADJ
iajs-801	6	9	defense	defense	NOUN
iajs-801	6	10	insured	insure	VERB
iajs-801	6	11	higher	high	ADJ
iajs-801	6	12	free	free	ADJ
iajs-801	6	13	radical	radical	ADJ
iajs-801	6	14	generation	generation	NOUN
iajs-801	6	15	in	in	ADP
iajs-801	6	16	diabetic	diabetic	ADJ
iajs-801	6	17	patients	patient	NOUN
iajs-801	6	18	which	which	PRON
iajs-801	6	19	is	be	AUX
iajs-801	6	20	conformed	conform	VERB
iajs-801	6	21	by	by	ADP
iajs-801	6	22	the	the	DET
iajs-801	6	23	high	high	ADJ
iajs-801	6	24	α1	α1	PROPN
iajs-801	6	25	-	-	PUNCT
iajs-801	6	26	antitrypsine	antitrypsine	NOUN
iajs-801	6	27	level	level	NOUN
iajs-801	6	28	in	in	ADP
iajs-801	6	29	the	the	DET
iajs-801	6	30	sera	sera	NOUN
iajs-801	6	31	.	.	PUNCT
iajs-801	7	1	key	key	ADJ
iajs-801	7	2	words	word	NOUN
iajs-801	7	3	:	:	PUNCT
iajs-801	7	4	α1	α1	NOUN
iajs-801	7	5	-	-	PUNCT
iajs-801	7	6	antitrypsine	antitrypsine	NOUN
iajs-801	7	7	,	,	PUNCT
iajs-801	7	8	glutathione	glutathione	NOUN
iajs-801	7	9	,	,	PUNCT
iajs-801	7	10	diabetes	diabetes	NOUN
iajs-801	7	11	mellitus	mellitus	NOUN
iajs-801	7	12	type	type	VERB
iajs-801	7	13	2	2	NUM
iajs-801	7	14	introduction	introduction	NOUN
iajs-801	7	15	diabetes	diabetes	NOUN
iajs-801	7	16	mellitus	mellitus	NOUN
iajs-801	8	1	dm	dm	PROPN
iajs-801	8	2	is	be	AUX
iajs-801	8	3	a	a	DET
iajs-801	8	4	group	group	NOUN
iajs-801	8	5	of	of	ADP
iajs-801	8	6	metabolic	metabolic	NOUN
iajs-801	8	7	disorders	disorder	NOUN
iajs-801	8	8	of	of	ADP
iajs-801	8	9	carbohydrate	carbohydrate	ADJ
iajs-801	8	10	metabolism	metabolism	NOUN
iajs-801	8	11	in	in	ADP
iajs-801	8	12	which	which	PRON
iajs-801	8	13	glucose	glucose	NOUN
iajs-801	8	14	in	in	ADP
iajs-801	8	15	underutilized	underutilize	VERB
iajs-801	8	16	by	by	ADP
iajs-801	8	17	the	the	DET
iajs-801	8	18	body	body	NOUN
iajs-801	8	19	tissue	tissue	NOUN
iajs-801	8	20	,	,	PUNCT
iajs-801	8	21	producing	produce	VERB
iajs-801	8	22	hyperglycemia	hyperglycemia	NOUN
iajs-801	8	23	.	.	PUNCT
iajs-801	9	1	some	some	DET
iajs-801	9	2	patients	patient	NOUN
iajs-801	9	3	may	may	AUX
iajs-801	9	4	develop	develop	VERB
iajs-801	9	5	life	life	NOUN
iajs-801	9	6	threatening	threaten	VERB
iajs-801	9	7	conditions	condition	NOUN
iajs-801	9	8	like	like	ADP
iajs-801	9	9	keto	keto	NOUN
iajs-801	9	10	-	-	PUNCT
iajs-801	9	11	acidosis	acidosis	NOUN
iajs-801	9	12	and	and	CCONJ
iajs-801	9	13	coma.[1	coma.[1	NOUN
iajs-801	9	14	]	]	PUNCT
iajs-801	9	15	over	over	ADP
iajs-801	9	16	the	the	DET
iajs-801	9	17	last	last	ADJ
iajs-801	9	18	decade	decade	NOUN
iajs-801	9	19	,	,	PUNCT
iajs-801	9	20	there	there	PRON
iajs-801	9	21	has	have	AUX
iajs-801	9	22	been	be	AUX
iajs-801	9	23	a	a	DET
iajs-801	9	24	significant	significant	ADJ
iajs-801	9	25	interest	interest	NOUN
iajs-801	9	26	in	in	ADP
iajs-801	9	27	oxidative	oxidative	ADJ
iajs-801	9	28	stress	stress	NOUN
iajs-801	9	29	and	and	CCONJ
iajs-801	9	30	its	its	PRON
iajs-801	9	31	role	role	NOUN
iajs-801	9	32	in	in	ADP
iajs-801	9	33	the	the	DET
iajs-801	9	34	development	development	NOUN
iajs-801	9	35	of	of	ADP
iajs-801	9	36	complications	complication	NOUN
iajs-801	9	37	in	in	ADP
iajs-801	9	38	diabetic	diabetic	ADJ
iajs-801	9	39	patients.[2	patients.[2	NOUN
iajs-801	9	40	]	]	PUNCT
iajs-801	9	41	glutathione	glutathione	NOUN
iajs-801	9	42	(	(	PUNCT
iajs-801	9	43	gsh	gsh	PROPN
iajs-801	9	44	)	)	PUNCT
iajs-801	9	45	(	(	PUNCT
iajs-801	9	46	γ	γ	X
iajs-801	9	47	-	-	PUNCT
iajs-801	9	48	glutamyl	glutamyl	ADJ
iajs-801	9	49	-	-	PUNCT
iajs-801	9	50	cysteinyl	cysteinyl	NOUN
iajs-801	9	51	glycine	glycine	NOUN
iajs-801	9	52	)	)	PUNCT
iajs-801	9	53	is	be	AUX
iajs-801	9	54	a	a	DET
iajs-801	9	55	tripeptide	tripeptide	NOUN
iajs-801	9	56	consisting	consist	VERB
iajs-801	9	57	of	of	ADP
iajs-801	9	58	glutamic	glutamic	ADJ
iajs-801	9	59	acid	acid	NOUN
iajs-801	9	60	,	,	PUNCT
iajs-801	9	61	cysteine	cysteine	NOUN
iajs-801	9	62	and	and	CCONJ
iajs-801	9	63	glycine	glycine	NOUN
iajs-801	9	64	.	.	PUNCT
iajs-801	10	1	a	a	DET
iajs-801	10	2	number	number	NOUN
iajs-801	10	3	of	of	ADP
iajs-801	10	4	potentially	potentially	ADV
iajs-801	10	5	toxic	toxic	ADJ
iajs-801	10	6	electrophilic	electrophilic	ADJ
iajs-801	10	7	xenobiotics	xenobiotic	NOUN
iajs-801	10	8	are	be	AUX
iajs-801	10	9	conjugated	conjugate	VERB
iajs-801	10	10	to	to	ADP
iajs-801	10	11	the	the	DET
iajs-801	10	12	nucleophilic	nucleophilic	ADJ
iajs-801	10	13	gsh	gsh	NOUN
iajs-801	10	14	in	in	ADP
iajs-801	10	15	reactions	reaction	NOUN
iajs-801	10	16	that	that	PRON
iajs-801	10	17	can	can	AUX
iajs-801	10	18	be	be	AUX
iajs-801	10	19	represented	represent	VERB
iajs-801	10	20	as	as	SCONJ
iajs-801	10	21	follows	follow	VERB
iajs-801	10	22	:	:	PUNCT
iajs-801	11	1	2r	2r	NUM
iajs-801	12	1	+	+	CCONJ
iajs-801	12	2	2gsh	2gsh	PROPN
iajs-801	12	3	→	→	SYM
iajs-801	12	4	2r	2r	NUM
iajs-801	12	5	–	–	PUNCT
iajs-801	12	6	s	s	NOUN
iajs-801	12	7	–	–	PUNCT
iajs-801	12	8	g	g	PROPN
iajs-801	12	9	+	+	PROPN
iajs-801	12	10	h2	h2	PROPN
iajs-801	12	11	where	where	SCONJ
iajs-801	12	12	r=	r=	VERB
iajs-801	12	13	an	an	DET
iajs-801	12	14	electrophilic	electrophilic	ADJ
iajs-801	12	15	xenobiotic	xenobiotic	ADJ
iajs-801	12	16	if	if	SCONJ
iajs-801	12	17	the	the	DET
iajs-801	12	18	potentially	potentially	ADV
iajs-801	12	19	toxic	toxic	ADJ
iajs-801	12	20	xenobioties	xenobiotie	NOUN
iajs-801	12	21	were	be	AUX
iajs-801	12	22	not	not	PART
iajs-801	12	23	conjugated	conjugate	VERB
iajs-801	12	24	to	to	PART
iajs-801	12	25	gsh	gsh	VERB
iajs-801	12	26	they	they	PRON
iajs-801	12	27	would	would	AUX
iajs-801	12	28	be	be	AUX
iajs-801	12	29	free	free	ADJ
iajs-801	12	30	to	to	PART
iajs-801	12	31	combine	combine	VERB
iajs-801	12	32	covalently	covalently	ADV
iajs-801	12	33	with	with	ADP
iajs-801	12	34	dna	dna	PROPN
iajs-801	12	35	,	,	PUNCT
iajs-801	12	36	rna	rna	NOUN
iajs-801	12	37	or	or	CCONJ
iajs-801	12	38	cell	cell	NOUN
iajs-801	12	39	protein	protein	NOUN
iajs-801	12	40	and	and	CCONJ
iajs-801	12	41	could	could	AUX
iajs-801	12	42	thus	thus	ADV
iajs-801	12	43	lead	lead	VERB
iajs-801	12	44	to	to	ADP
iajs-801	12	45	serious	serious	ADJ
iajs-801	12	46	cell	cell	NOUN
iajs-801	12	47	damage.[2	damage.[2	ADV
iajs-801	12	48	]	]	X
iajs-801	12	49	gsh	gsh	PROPN
iajs-801	12	50	has	have	VERB
iajs-801	12	51	other	other	ADJ
iajs-801	12	52	important	important	ADJ
iajs-801	12	53	functions	function	NOUN
iajs-801	12	54	in	in	ADP
iajs-801	12	55	human	human	ADJ
iajs-801	12	56	cells	cell	NOUN
iajs-801	12	57	apart	apart	ADV
iajs-801	12	58	from	from	ADP
iajs-801	12	59	its	its	PRON
iajs-801	12	60	role	role	NOUN
iajs-801	12	61	in	in	ADP
iajs-801	12	62	xenobiotic	xenobiotic	ADJ
iajs-801	12	63	metabolism	metabolism	NOUN
iajs-801	12	64	.	.	PUNCT
iajs-801	13	1	it	it	PRON
iajs-801	13	2	participates	participate	VERB
iajs-801	13	3	in	in	ADP
iajs-801	13	4	the	the	DET
iajs-801	13	5	decomposition	decomposition	NOUN
iajs-801	13	6	of	of	ADP
iajs-801	13	7	potentially	potentially	ADV
iajs-801	13	8	toxic	toxic	ADJ
iajs-801	13	9	hydrogen	hydrogen	NOUN
iajs-801	13	10	peroxide	peroxide	NOUN
iajs-801	13	11	in	in	ADP
iajs-801	13	12	the	the	DET
iajs-801	13	13	reaction	reaction	NOUN
iajs-801	13	14	catalyzed	catalyze	VERB
iajs-801	13	15	by	by	ADP
iajs-801	13	16	glutathione	glutathione	NOUN
iajs-801	13	17	peroxidase	peroxidase	NOUN
iajs-801	13	18	,	,	PUNCT
iajs-801	13	19	it	it	PRON
iajs-801	13	20	is	be	AUX
iajs-801	13	21	an	an	DET
iajs-801	13	22	important	important	ADJ
iajs-801	13	23	intracellular	intracellular	ADJ
iajs-801	13	24	reductant	reductant	NOUN
iajs-801	13	25	helping	help	VERB
iajs-801	13	26	to	to	PART
iajs-801	13	27	maintain	maintain	VERB
iajs-801	13	28	essential	essential	ADJ
iajs-801	13	29	sh	sh	NOUN
iajs-801	13	30	groups	group	NOUN
iajs-801	13	31	of	of	ADP
iajs-801	13	32	enzymes	enzyme	NOUN
iajs-801	13	33	in	in	ADP
iajs-801	13	34	their	their	PRON
iajs-801	13	35	reduced	reduced	ADJ
iajs-801	13	36	state	state	NOUN
iajs-801	13	37	.	.	PUNCT
iajs-801	14	1	a	a	DET
iajs-801	14	2	metabolic	metabolic	NOUN
iajs-801	14	3	cycle	cycle	NOUN
iajs-801	14	4	involving	involve	VERB
iajs-801	14	5	gsh	gsh	PROPN
iajs-801	14	6	as	as	ADP
iajs-801	14	7	a	a	DET
iajs-801	14	8	carrier	carrier	NOUN
iajs-801	14	9	has	have	AUX
iajs-801	14	10	been	be	AUX
iajs-801	14	11	implicated	implicate	VERB
iajs-801	14	12	in	in	ADP
iajs-801	14	13	the	the	DET
iajs-801	14	14	transport	transport	NOUN
iajs-801	14	15	of	of	ADP
iajs-801	14	16	certain	certain	ADJ
iajs-801	14	17	amino	amino	NOUN
iajs-801	14	18	acid	acid	NOUN
iajs-801	14	19	across	across	ADP
iajs-801	14	20	membranes	membrane	NOUN
iajs-801	14	21	in	in	ADP
iajs-801	14	22	the	the	DET
iajs-801	14	23	kidney.[3	kidney.[3	NOUN
iajs-801	14	24	]	]	X
iajs-801	14	25	ibn	ibn	PROPN
iajs-801	14	26	alhaitham	alhaitham	NOUN
iajs-801	14	27	j.	j.	PROPN
iajs-801	14	28	for	for	ADP
iajs-801	14	29	pure	pure	ADJ
iajs-801	14	30	&	&	CCONJ
iajs-801	14	31	appl	appl	PROPN
iajs-801	14	32	.	.	PUNCT
iajs-801	15	1	sci	sci	PROPN
iajs-801	15	2	.	.	PUNCT
iajs-801	15	3	vol.24	vol.24	NOUN
iajs-801	15	4	(	(	PUNCT
iajs-801	15	5	1	1	NUM
iajs-801	15	6	)	)	PUNCT
iajs-801	15	7	2011	2011	NUM
iajs-801	15	8	alpha	alpha	NOUN
iajs-801	15	9	1	1	NUM
iajs-801	15	10	-	-	PUNCT
iajs-801	15	11	antitrypsine	antitrypsine	NOUN
iajs-801	15	12	is	be	AUX
iajs-801	15	13	among	among	ADP
iajs-801	15	14	positive	positive	ADJ
iajs-801	15	15	acute	acute	NOUN
iajs-801	15	16	phase	phase	NOUN
iajs-801	15	17	proteins	protein	NOUN
iajs-801	15	18	(	(	PUNCT
iajs-801	15	19	apps	app	NOUN
iajs-801	15	20	)	)	PUNCT
iajs-801	15	21	which	which	PRON
iajs-801	15	22	is	be	AUX
iajs-801	15	23	a	a	DET
iajs-801	15	24	major	major	ADJ
iajs-801	15	25	pathophysiologic	pathophysiologic	ADJ
iajs-801	15	26	phenomenon	phenomenon	NOUN
iajs-801	15	27	that	that	PRON
iajs-801	15	28	accompanies	accompany	VERB
iajs-801	15	29	inflammation	inflammation	NOUN
iajs-801	15	30	either	either	CCONJ
iajs-801	15	31	acute	acute	ADJ
iajs-801	15	32	or	or	CCONJ
iajs-801	15	33	chronic[4	chronic[4	NOUN
iajs-801	15	34	]	]	X
iajs-801	15	35	,	,	PUNCT
iajs-801	15	36	the	the	DET
iajs-801	15	37	release	release	NOUN
iajs-801	15	38	of	of	ADP
iajs-801	15	39	inflammatory	inflammatory	ADJ
iajs-801	15	40	molecules	molecule	NOUN
iajs-801	15	41	(	(	PUNCT
iajs-801	15	42	cytokines	cytokine	NOUN
iajs-801	15	43	)	)	PUNCT
iajs-801	15	44	changes	change	VERB
iajs-801	15	45	the	the	DET
iajs-801	15	46	level	level	NOUN
iajs-801	15	47	of	of	ADP
iajs-801	15	48	apps	app	NOUN
iajs-801	15	49	as	as	ADV
iajs-801	15	50	well	well	ADV
iajs-801	15	51	as	as	ADP
iajs-801	15	52	a	a	DET
iajs-801	15	53	number	number	NOUN
iajs-801	15	54	of	of	ADP
iajs-801	15	55	behavioral	behavioral	ADJ
iajs-801	15	56	,	,	PUNCT
iajs-801	15	57	physiologic	physiologic	ADJ
iajs-801	15	58	,	,	PUNCT
iajs-801	15	59	biochemical	biochemical	ADJ
iajs-801	15	60	and	and	CCONJ
iajs-801	15	61	nutritional	nutritional	ADJ
iajs-801	15	62	changes	change	NOUN
iajs-801	15	63	are	be	AUX
iajs-801	15	64	induced.[5	induced.[5	NOUN
iajs-801	15	65	]	]	X
iajs-801	15	66	the	the	DET
iajs-801	15	67	aim	aim	NOUN
iajs-801	15	68	of	of	ADP
iajs-801	15	69	the	the	DET
iajs-801	15	70	present	present	ADJ
iajs-801	15	71	study	study	NOUN
iajs-801	15	72	is	be	AUX
iajs-801	15	73	to	to	PART
iajs-801	15	74	evaluate	evaluate	VERB
iajs-801	15	75	the	the	DET
iajs-801	15	76	levels	level	NOUN
iajs-801	15	77	of	of	ADP
iajs-801	15	78	gsh	gsh	PROPN
iajs-801	15	79	as	as	ADP
iajs-801	15	80	a	a	DET
iajs-801	15	81	major	major	ADJ
iajs-801	15	82	endogenous	endogenous	ADJ
iajs-801	15	83	antioxidant	antioxidant	NOUN
iajs-801	15	84	and	and	CCONJ
iajs-801	15	85	α1	α1	NOUN
iajs-801	15	86	-	-	PUNCT
iajs-801	15	87	antitrypsine	antitrypsine	NOUN
iajs-801	15	88	as	as	ADP
iajs-801	15	89	a	a	DET
iajs-801	15	90	reactant	reactant	NOUN
iajs-801	15	91	modulated	modulate	VERB
iajs-801	15	92	during	during	ADP
iajs-801	15	93	inflammatory	inflammatory	ADJ
iajs-801	15	94	diseases	disease	NOUN
iajs-801	15	95	in	in	ADP
iajs-801	15	96	the	the	DET
iajs-801	15	97	sera	sera	NOUN
iajs-801	15	98	of	of	ADP
iajs-801	15	99	type	type	NOUN
iajs-801	15	100	2	2	NUM
iajs-801	15	101	dm	dm	NOUN
iajs-801	15	102	iraqi	iraqi	ADJ
iajs-801	15	103	patients	patient	NOUN
iajs-801	15	104	and	and	CCONJ
iajs-801	15	105	to	to	PART
iajs-801	15	106	correlate	correlate	VERB
iajs-801	15	107	both	both	DET
iajs-801	15	108	parameters	parameter	NOUN
iajs-801	15	109	.	.	PUNCT
iajs-801	16	1	experimental	experimental	ADJ
iajs-801	16	2	subjects	subject	NOUN
iajs-801	16	3	:	:	PUNCT
iajs-801	16	4	the	the	DET
iajs-801	16	5	study	study	NOUN
iajs-801	16	6	group	group	NOUN
iajs-801	16	7	comprised	comprise	VERB
iajs-801	16	8	20	20	NUM
iajs-801	16	9	patients	patient	NOUN
iajs-801	16	10	from	from	ADP
iajs-801	16	11	both	both	DET
iajs-801	16	12	sexes	sex	NOUN
iajs-801	16	13	with	with	ADP
iajs-801	16	14	type	type	NOUN
iajs-801	16	15	2	2	NUM
iajs-801	16	16	dm	dm	NOUN
iajs-801	16	17	diagnosed	diagnose	VERB
iajs-801	16	18	by	by	ADP
iajs-801	16	19	physicians	physician	NOUN
iajs-801	16	20	at	at	ADP
iajs-801	16	21	al	al	PROPN
iajs-801	16	22	-	-	PUNCT
iajs-801	16	23	kadhymia	kadhymia	PROPN
iajs-801	16	24	teaching	teach	VERB
iajs-801	16	25	hospital	hospital	NOUN
iajs-801	16	26	in	in	ADP
iajs-801	16	27	addition	addition	NOUN
iajs-801	16	28	to	to	ADP
iajs-801	16	29	ten	ten	NUM
iajs-801	16	30	healthy	healthy	ADJ
iajs-801	16	31	control	control	NOUN
iajs-801	16	32	matching	match	VERB
iajs-801	16	33	the	the	DET
iajs-801	16	34	age	age	NOUN
iajs-801	16	35	.	.	PUNCT
iajs-801	17	1	blood	blood	NOUN
iajs-801	17	2	samples	sample	NOUN
iajs-801	17	3	:	:	PUNCT
iajs-801	17	4	about	about	ADV
iajs-801	17	5	five	five	NUM
iajs-801	17	6	milliliters	milliliter	NOUN
iajs-801	17	7	of	of	ADP
iajs-801	17	8	venous	venous	ADJ
iajs-801	17	9	blood	blood	NOUN
iajs-801	17	10	were	be	AUX
iajs-801	17	11	collected	collect	VERB
iajs-801	17	12	from	from	ADP
iajs-801	17	13	each	each	DET
iajs-801	17	14	subject	subject	NOUN
iajs-801	17	15	in	in	ADP
iajs-801	17	16	the	the	DET
iajs-801	17	17	study	study	NOUN
iajs-801	17	18	after	after	ADP
iajs-801	17	19	a	a	DET
iajs-801	17	20	12	12	NUM
iajs-801	17	21	-	-	PUNCT
iajs-801	17	22	hour	hour	NOUN
iajs-801	17	23	fast	fast	ADV
iajs-801	17	24	.	.	PUNCT
iajs-801	18	1	the	the	DET
iajs-801	18	2	blood	blood	NOUN
iajs-801	18	3	samples	sample	NOUN
iajs-801	18	4	were	be	AUX
iajs-801	18	5	collected	collect	VERB
iajs-801	18	6	into	into	ADP
iajs-801	18	7	blastic	blastic	ADJ
iajs-801	18	8	tubes	tube	NOUN
iajs-801	18	9	,	,	PUNCT
iajs-801	18	10	left	leave	VERB
iajs-801	18	11	at	at	ADP
iajs-801	18	12	room	room	NOUN
iajs-801	18	13	temperature	temperature	NOUN
iajs-801	18	14	for	for	ADP
iajs-801	18	15	15	15	NUM
iajs-801	18	16	min	min	NOUN
iajs-801	18	17	then	then	ADV
iajs-801	18	18	centrifuged	centrifuge	VERB
iajs-801	18	19	at	at	ADP
iajs-801	18	20	3000	3000	NUM
iajs-801	18	21	rpm	rpm	NOUN
iajs-801	18	22	for	for	ADP
iajs-801	18	23	15	15	NUM
iajs-801	18	24	min	min	NOUN
iajs-801	18	25	.	.	PROPN
iajs-801	18	26	serum	serum	PROPN
iajs-801	18	27	was	be	AUX
iajs-801	18	28	separated	separate	VERB
iajs-801	18	29	and	and	CCONJ
iajs-801	18	30	aliquoted	aliquote	VERB
iajs-801	18	31	for	for	ADP
iajs-801	18	32	subsequent	subsequent	ADJ
iajs-801	18	33	measurement	measurement	NOUN
iajs-801	18	34	of	of	ADP
iajs-801	18	35	gsh	gsh	PROPN
iajs-801	18	36	and	and	CCONJ
iajs-801	18	37	α1	α1	PROPN
iajs-801	18	38	-	-	PUNCT
iajs-801	18	39	antitrypsine	antitrypsine	NOUN
iajs-801	18	40	..	..	PUNCT
iajs-801	18	41	laboratory	laboratory	NOUN
iajs-801	18	42	methods	method	NOUN
iajs-801	18	43	:	:	PUNCT
iajs-801	18	44	determination	determination	NOUN
iajs-801	18	45	of	of	ADP
iajs-801	18	46	glutathion	glutathion	NOUN
iajs-801	18	47	concentration	concentration	NOUN
iajs-801	18	48	gsh	gsh	PROPN
iajs-801	18	49	.	.	PUNCT
iajs-801	19	1	reduced	reduce	VERB
iajs-801	19	2	glutathione	glutathione	NOUN
iajs-801	19	3	was	be	AUX
iajs-801	19	4	determined	determine	VERB
iajs-801	19	5	according	accord	VERB
iajs-801	19	6	to	to	ADP
iajs-801	19	7	the	the	DET
iajs-801	19	8	method	method	NOUN
iajs-801	19	9	of	of	ADP
iajs-801	19	10	ellman[6	ellman[6	PROPN
iajs-801	19	11	]	]	PUNCT
iajs-801	19	12	,	,	PUNCT
iajs-801	19	13	based	base	VERB
iajs-801	19	14	on	on	ADP
iajs-801	19	15	the	the	DET
iajs-801	19	16	reaction	reaction	NOUN
iajs-801	19	17	of	of	ADP
iajs-801	19	18	aliphatic	aliphatic	ADJ
iajs-801	19	19	thiol	thiol	NOUN
iajs-801	19	20	compounds	compound	VERB
iajs-801	19	21	with	with	ADP
iajs-801	19	22	5,5	5,5	NOUN
iajs-801	19	23	-	-	PUNCT
iajs-801	19	24	dithiobis	dithiobis	NOUN
iajs-801	19	25	(	(	PUNCT
iajs-801	19	26	2	2	NUM
iajs-801	19	27	-	-	PUNCT
iajs-801	19	28	nitrobenzoic	nitrobenzoic	NOUN
iajs-801	19	29	acid)(dtnb	acid)(dtnb	NOUN
iajs-801	19	30	)	)	PUNCT
iajs-801	19	31	at	at	ADP
iajs-801	19	32	ph8	ph8	PROPN
iajs-801	19	33	.	.	PUNCT
iajs-801	20	1	the	the	DET
iajs-801	20	2	absorbance	absorbance	NOUN
iajs-801	20	3	of	of	ADP
iajs-801	20	4	the	the	DET
iajs-801	20	5	yellow	yellow	ADJ
iajs-801	20	6	chromagen	chromagen	NOUN
iajs-801	20	7	was	be	AUX
iajs-801	20	8	measured	measure	VERB
iajs-801	20	9	at	at	ADP
iajs-801	20	10	412	412	NUM
iajs-801	20	11	nm	nm	NOUN
iajs-801	20	12	and	and	CCONJ
iajs-801	20	13	is	be	AUX
iajs-801	20	14	directly	directly	ADV
iajs-801	20	15	proportional	proportional	ADJ
iajs-801	20	16	to	to	ADP
iajs-801	20	17	gsh	gsh	PROPN
iajs-801	20	18	concentration	concentration	NOUN
iajs-801	20	19	.	.	PUNCT
iajs-801	21	1	so	so	ADV
iajs-801	21	2	one	one	NUM
iajs-801	21	3	mole	mole	NOUN
iajs-801	21	4	of	of	ADP
iajs-801	21	5	the	the	DET
iajs-801	21	6	thiol	thiol	NOUN
iajs-801	21	7	produces	produce	VERB
iajs-801	21	8	one	one	NUM
iajs-801	21	9	mole	mole	NOUN
iajs-801	21	10	of	of	ADP
iajs-801	21	11	p	p	NOUN
iajs-801	21	12	-	-	PUNCT
iajs-801	21	13	nitro	nitro	NOUN
iajs-801	21	14	thiophenol	thiophenol	NOUN
iajs-801	21	15	anion	anion	NOUN
iajs-801	21	16	which	which	PRON
iajs-801	21	17	is	be	AUX
iajs-801	21	18	highly	highly	ADV
iajs-801	21	19	coloured	coloured	ADJ
iajs-801	21	20	(	(	PUNCT
iajs-801	21	21	ε=13600	ε=13600	PROPN
iajs-801	21	22	m	m	VERB
iajs-801	21	23	-1	-1	NOUN
iajs-801	21	24	cm	cm	NOUN
iajs-801	21	25	-1	-1	PUNCT
iajs-801	21	26	)	)	PUNCT
iajs-801	21	27	determination	determination	NOUN
iajs-801	21	28	of	of	ADP
iajs-801	21	29	α1	α1	PROPN
iajs-801	21	30	-	-	PUNCT
iajs-801	21	31	antitrypsine	antitrypsine	NOUN
iajs-801	21	32	:	:	PUNCT
iajs-801	21	33	alpha	alpha	NOUN
iajs-801	21	34	one	one	NUM
iajs-801	21	35	antitrypsine	antitrypsine	NOUN
iajs-801	21	36	was	be	AUX
iajs-801	21	37	measured	measure	VERB
iajs-801	21	38	in	in	ADP
iajs-801	21	39	the	the	DET
iajs-801	21	40	sera	sera	NOUN
iajs-801	21	41	of	of	ADP
iajs-801	21	42	patients	patient	NOUN
iajs-801	21	43	and	and	CCONJ
iajs-801	21	44	healthy	healthy	ADJ
iajs-801	21	45	control	control	NOUN
iajs-801	21	46	groups	group	NOUN
iajs-801	21	47	using	use	VERB
iajs-801	21	48	a	a	DET
iajs-801	21	49	ready	ready	ADJ
iajs-801	21	50	kit	kit	NOUN
iajs-801	21	51	from	from	ADP
iajs-801	21	52	bindarid	bindarid	PROPN
iajs-801	21	53	uk	uk	PROPN
iajs-801	21	54	rno	rno	PROPN
iajs-801	21	55	34.3	34.3	NUM
iajs-801	21	56	.	.	PUNCT
iajs-801	22	1	the	the	DET
iajs-801	22	2	method	method	NOUN
iajs-801	22	3	invaders	invader	VERB
iajs-801	22	4	antigen	antigen	ADV
iajs-801	22	5	diffusing	diffuse	VERB
iajs-801	22	6	radially	radially	ADV
iajs-801	22	7	from	from	ADP
iajs-801	22	8	a	a	DET
iajs-801	22	9	cylindrical	cylindrical	ADJ
iajs-801	22	10	well	well	NOUN
iajs-801	22	11	through	through	ADP
iajs-801	22	12	an	an	DET
iajs-801	22	13	agarose	agarose	NOUN
iajs-801	22	14	gel	gel	NOUN
iajs-801	22	15	containing	contain	VERB
iajs-801	22	16	an	an	DET
iajs-801	22	17	appropriate	appropriate	ADJ
iajs-801	22	18	mono	mono	NOUN
iajs-801	22	19	-	-	PUNCT
iajs-801	22	20	specific	specific	ADJ
iajs-801	22	21	antibody	antibody	NOUN
iajs-801	22	22	.	.	PUNCT
iajs-801	23	1	antibodyantigencomplexes	antibodyantigencomplexe	NOUN
iajs-801	23	2	are	be	AUX
iajs-801	23	3	formed	form	VERB
iajs-801	23	4	which	which	PRON
iajs-801	23	5	,	,	PUNCT
iajs-801	23	6	under	under	ADP
iajs-801	23	7	the	the	DET
iajs-801	23	8	right	right	ADJ
iajs-801	23	9	conditions	condition	NOUN
iajs-801	23	10	,	,	PUNCT
iajs-801	23	11	will	will	AUX
iajs-801	23	12	form	form	VERB
iajs-801	23	13	a	a	DET
iajs-801	23	14	precipitin	precipitin	ADJ
iajs-801	23	15	ring	ring	NOUN
iajs-801	23	16	.	.	PUNCT
iajs-801	24	1	the	the	DET
iajs-801	24	2	ring	ring	NOUN
iajs-801	24	3	size	size	NOUN
iajs-801	24	4	will	will	AUX
iajs-801	24	5	increase	increase	VERB
iajs-801	24	6	until	until	SCONJ
iajs-801	24	7	equilibrium	equilibrium	NOUN
iajs-801	24	8	is	be	AUX
iajs-801	24	9	reached	reach	VERB
iajs-801	24	10	between	between	ADP
iajs-801	24	11	the	the	DET
iajs-801	24	12	formation	formation	NOUN
iajs-801	24	13	and	and	CCONJ
iajs-801	24	14	breakdown	breakdown	NOUN
iajs-801	24	15	of	of	ADP
iajs-801	24	16	these	these	DET
iajs-801	24	17	complexes	complex	NOUN
iajs-801	24	18	,	,	PUNCT
iajs-801	24	19	this	this	DET
iajs-801	24	20	point	point	NOUN
iajs-801	24	21	is	be	AUX
iajs-801	24	22	termed	term	VERB
iajs-801	24	23	completion	completion	NOUN
iajs-801	24	24	.	.	PUNCT
iajs-801	25	1	at	at	ADP
iajs-801	25	2	this	this	DET
iajs-801	25	3	stage	stage	NOUN
iajs-801	25	4	,	,	PUNCT
iajs-801	25	5	a	a	DET
iajs-801	25	6	linear	linear	ADJ
iajs-801	25	7	relationship	relationship	NOUN
iajs-801	25	8	exists	exist	VERB
iajs-801	25	9	between	between	ADP
iajs-801	25	10	the	the	DET
iajs-801	25	11	square	square	NOUN
iajs-801	25	12	of	of	ADP
iajs-801	25	13	this	this	DET
iajs-801	25	14	ring	ring	NOUN
iajs-801	25	15	diameter	diameter	NOUN
iajs-801	25	16	and	and	CCONJ
iajs-801	25	17	the	the	DET
iajs-801	25	18	antigen	antigen	ADJ
iajs-801	25	19	concentration	concentration	NOUN
iajs-801	25	20	.	.	PUNCT
iajs-801	26	1	by	by	ADP
iajs-801	26	2	measuring	measure	VERB
iajs-801	26	3	the	the	DET
iajs-801	26	4	ring	ring	NOUN
iajs-801	26	5	diameters	diameter	NOUN
iajs-801	26	6	produced	produce	VERB
iajs-801	26	7	by	by	ADP
iajs-801	26	8	a	a	DET
iajs-801	26	9	number	number	NOUN
iajs-801	26	10	of	of	ADP
iajs-801	26	11	samples	sample	NOUN
iajs-801	26	12	of	of	ADP
iajs-801	26	13	known	know	VERB
iajs-801	26	14	concentration	concentration	NOUN
iajs-801	26	15	,	,	PUNCT
iajs-801	26	16	a	a	DET
iajs-801	26	17	calibration	calibration	NOUN
iajs-801	26	18	curve	curve	NOUN
iajs-801	26	19	may	may	AUX
iajs-801	26	20	be	be	AUX
iajs-801	26	21	constructed	construct	VERB
iajs-801	26	22	.	.	PUNCT
iajs-801	27	1	the	the	DET
iajs-801	27	2	concentration	concentration	NOUN
iajs-801	27	3	of	of	ADP
iajs-801	27	4	the	the	DET
iajs-801	27	5	antigen	antigen	NOUN
iajs-801	27	6	in	in	ADP
iajs-801	27	7	an	an	DET
iajs-801	27	8	unknown	unknown	ADJ
iajs-801	27	9	sample	sample	NOUN
iajs-801	27	10	may	may	AUX
iajs-801	27	11	then	then	ADV
iajs-801	27	12	be	be	AUX
iajs-801	27	13	determined	determine	VERB
iajs-801	27	14	by	by	ADP
iajs-801	27	15	measuring	measure	VERB
iajs-801	27	16	the	the	DET
iajs-801	27	17	ring	ring	NOUN
iajs-801	27	18	diameter	diameter	NOUN
iajs-801	27	19	produced	produce	VERB
iajs-801	27	20	by	by	ADP
iajs-801	27	21	that	that	DET
iajs-801	27	22	sample	sample	NOUN
iajs-801	27	23	and	and	CCONJ
iajs-801	27	24	reading	read	VERB
iajs-801	27	25	off	off	ADP
iajs-801	27	26	the	the	DET
iajs-801	27	27	calibration	calibration	NOUN
iajs-801	27	28	curve[7	curve[7	NOUN
iajs-801	27	29	]	]	PUNCT
iajs-801	27	30	.	.	PUNCT
iajs-801	28	1	statistical	statistical	ADJ
iajs-801	28	2	analysis	analysis	NOUN
iajs-801	28	3	:	:	PUNCT
iajs-801	28	4	data	datum	NOUN
iajs-801	28	5	are	be	AUX
iajs-801	28	6	expressed	express	VERB
iajs-801	28	7	as	as	ADP
iajs-801	28	8	mean	mean	NOUN
iajs-801	28	9	standard	standard	ADJ
iajs-801	28	10	deviation	deviation	NOUN
iajs-801	28	11	of	of	ADP
iajs-801	28	12	(	(	PUNCT
iajs-801	28	13	mean	mean	PROPN
iajs-801	28	14	±s.d	±s.d	PROPN
iajs-801	28	15	.	.	PUNCT
iajs-801	28	16	)	)	PUNCT
iajs-801	28	17	.	.	PUNCT
iajs-801	29	1	statistical	statistical	ADJ
iajs-801	29	2	significance	significance	NOUN
iajs-801	29	3	was	be	AUX
iajs-801	29	4	determined	determine	VERB
iajs-801	29	5	by	by	ADP
iajs-801	29	6	unpaired	unpaired	ADJ
iajs-801	29	7	student	student	NOUN
iajs-801	29	8	's	's	PART
iajs-801	29	9	,	,	PUNCT
iajs-801	29	10	t	t	NOUN
iajs-801	29	11	-	-	PUNCT
iajs-801	29	12	test	test	NOUN
iajs-801	29	13	.	.	PUNCT
iajs-801	30	1	one	one	NUM
iajs-801	30	2	way	way	NOUN
iajs-801	30	3	of	of	ADP
iajs-801	30	4	analysis	analysis	NOUN
iajs-801	30	5	of	of	ADP
iajs-801	30	6	variance	variance	NOUN
iajs-801	30	7	(	(	PUNCT
iajs-801	30	8	anova	anova	PROPN
iajs-801	30	9	)	)	PUNCT
iajs-801	30	10	is	be	AUX
iajs-801	30	11	followed	follow	VERB
iajs-801	30	12	by	by	ADP
iajs-801	30	13	pearson	pearson	PROPN
iajs-801	30	14	's	's	PART
iajs-801	30	15	correlation	correlation	NOUN
iajs-801	30	16	(	(	PUNCT
iajs-801	30	17	r	r	NOUN
iajs-801	30	18	)	)	PUNCT
iajs-801	30	19	.	.	PUNCT
iajs-801	31	1	p	p	NOUN
iajs-801	31	2	values	value	NOUN
iajs-801	31	3	equal	equal	ADJ
iajs-801	31	4	or	or	CCONJ
iajs-801	31	5	lower	low	ADJ
iajs-801	31	6	than	than	ADP
iajs-801	31	7	0.05	0.05	NUM
iajs-801	31	8	were	be	AUX
iajs-801	31	9	considered	consider	VERB
iajs-801	31	10	statistically	statistically	ADV
iajs-801	31	11	significant	significant	ADJ
iajs-801	31	12	.	.	PUNCT
iajs-801	32	1	ibn	ibn	PROPN
iajs-801	32	2	alhaitham	alhaitham	PROPN
iajs-801	32	3	j.	j.	PROPN
iajs-801	32	4	for	for	ADP
iajs-801	32	5	pure	pure	ADJ
iajs-801	32	6	&	&	CCONJ
iajs-801	32	7	appl	appl	PROPN
iajs-801	32	8	.	.	PUNCT
iajs-801	33	1	sci	sci	PROPN
iajs-801	33	2	.	.	PUNCT
iajs-801	33	3	vol.24	vol.24	NOUN
iajs-801	33	4	(	(	PUNCT
iajs-801	33	5	1	1	NUM
iajs-801	33	6	)	)	PUNCT
iajs-801	33	7	2011	2011	NUM
iajs-801	33	8	results	result	NOUN
iajs-801	33	9	and	and	CCONJ
iajs-801	33	10	discussion	discussion	NOUN
iajs-801	33	11	reduced	reduce	VERB
iajs-801	33	12	glutathione	glutathione	NOUN
iajs-801	33	13	gsh	gsh	PROPN
iajs-801	33	14	:	:	PUNCT
iajs-801	33	15	table1	table1	PROPN
iajs-801	33	16	shows	show	VERB
iajs-801	33	17	the	the	DET
iajs-801	33	18	level	level	NOUN
iajs-801	33	19	mean	mean	VERB
iajs-801	33	20	±sd	±sd	PROPN
iajs-801	33	21	of	of	ADP
iajs-801	33	22	gsh	gsh	PROPN
iajs-801	33	23	in	in	ADP
iajs-801	33	24	the	the	DET
iajs-801	33	25	serum	serum	NOUN
iajs-801	33	26	of	of	ADP
iajs-801	33	27	type	type	NOUN
iajs-801	33	28	2	2	NUM
iajs-801	33	29	dm	dm	NOUN
iajs-801	33	30	patient	patient	ADJ
iajs-801	33	31	and	and	CCONJ
iajs-801	33	32	healthy	healthy	ADJ
iajs-801	33	33	control	control	NOUN
iajs-801	33	34	,	,	PUNCT
iajs-801	33	35	a	a	DET
iajs-801	33	36	significant	significant	ADJ
iajs-801	33	37	decrease	decrease	NOUN
iajs-801	33	38	in	in	ADP
iajs-801	33	39	gsh	gsh	PROPN
iajs-801	33	40	level	level	NOUN
iajs-801	33	41	in	in	ADP
iajs-801	33	42	the	the	DET
iajs-801	33	43	serum	serum	NOUN
iajs-801	33	44	of	of	ADP
iajs-801	33	45	type	type	NOUN
iajs-801	33	46	2	2	NUM
iajs-801	33	47	dm	dm	NOUN
iajs-801	33	48	patient	patient	NOUN
iajs-801	33	49	compared	compare	VERB
iajs-801	33	50	with	with	ADP
iajs-801	33	51	the	the	DET
iajs-801	33	52	control	control	NOUN
iajs-801	33	53	was	be	AUX
iajs-801	33	54	found	find	VERB
iajs-801	33	55	with	with	ADP
iajs-801	33	56	values	value	NOUN
iajs-801	33	57	1.092	1.092	NUM
iajs-801	33	58	±	±	NUM
iajs-801	33	59	0.204	0.204	NUM
iajs-801	33	60	m	m	NOUN
iajs-801	33	61	and	and	CCONJ
iajs-801	33	62	3.4	3.4	NUM
iajs-801	33	63	±	±	NOUN
iajs-801	33	64	0.529	0.529	NUM
iajs-801	33	65	m	m	NOUN
iajs-801	33	66	respectively	respectively	ADV
iajs-801	33	67	.	.	PUNCT
iajs-801	34	1	these	these	DET
iajs-801	34	2	results	result	NOUN
iajs-801	34	3	are	be	AUX
iajs-801	34	4	in	in	ADP
iajs-801	34	5	agreement	agreement	NOUN
iajs-801	34	6	with	with	ADP
iajs-801	34	7	recent	recent	ADJ
iajs-801	34	8	study	study	NOUN
iajs-801	34	9	reported	report	VERB
iajs-801	34	10	that	that	SCONJ
iajs-801	34	11	a	a	DET
iajs-801	34	12	significant	significant	ADJ
iajs-801	34	13	decrease	decrease	NOUN
iajs-801	34	14	in	in	ADP
iajs-801	34	15	gsh	gsh	PROPN
iajs-801	34	16	level	level	NOUN
iajs-801	34	17	in	in	ADP
iajs-801	34	18	patient	patient	NOUN
iajs-801	34	19	with	with	ADP
iajs-801	34	20	type	type	NOUN
iajs-801	34	21	2	2	NUM
iajs-801	34	22	dm	dm	NOUN
iajs-801	34	23	[	[	NOUN
iajs-801	34	24	8	8	NUM
iajs-801	34	25	]	]	PUNCT
iajs-801	34	26	.	.	PUNCT
iajs-801	35	1	reduced	reduce	VERB
iajs-801	35	2	glutathione	glutathione	NOUN
iajs-801	35	3	is	be	AUX
iajs-801	35	4	physiological	physiological	ADJ
iajs-801	35	5	free	free	ADJ
iajs-801	35	6	radical	radical	ADJ
iajs-801	35	7	scavengers.thus	scavengers.thus	NUM
iajs-801	35	8	glutathione	glutathione	NOUN
iajs-801	35	9	plays	play	VERB
iajs-801	35	10	a	a	DET
iajs-801	35	11	central	central	ADJ
iajs-801	35	12	role	role	NOUN
iajs-801	35	13	in	in	ADP
iajs-801	35	14	antioxidant	antioxidant	ADJ
iajs-801	35	15	defense	defense	NOUN
iajs-801	36	1	[	[	X
iajs-801	36	2	9	9	NUM
iajs-801	36	3	]	]	PUNCT
iajs-801	36	4	.	.	PUNCT
iajs-801	37	1	in	in	ADP
iajs-801	37	2	hyperglycemic	hyperglycemic	ADJ
iajs-801	37	3	condition	condition	NOUN
iajs-801	37	4	,	,	PUNCT
iajs-801	37	5	glucose	glucose	NOUN
iajs-801	37	6	is	be	AUX
iajs-801	37	7	preferentially	preferentially	ADV
iajs-801	37	8	used	use	VERB
iajs-801	37	9	in	in	ADP
iajs-801	37	10	the	the	DET
iajs-801	37	11	polyol	polyol	NOUN
iajs-801	37	12	pathway	pathway	NOUN
iajs-801	37	13	that	that	PRON
iajs-801	37	14	consumes	consume	VERB
iajs-801	37	15	nadph	nadph	ADJ
iajs-801	37	16	which	which	PRON
iajs-801	37	17	is	be	AUX
iajs-801	37	18	necessary	necessary	ADJ
iajs-801	37	19	for	for	ADP
iajs-801	37	20	gsh	gsh	PROPN
iajs-801	37	21	regeneration	regeneration	NOUN
iajs-801	37	22	by	by	ADP
iajs-801	37	23	the	the	DET
iajs-801	37	24	glutathione	glutathione	NOUN
iajs-801	37	25	reductase	reductase	NOUN
iajs-801	37	26	enzyme	enzyme	NOUN
iajs-801	37	27	[	[	NOUN
iajs-801	37	28	10	10	NUM
iajs-801	37	29	]	]	PUNCT
iajs-801	37	30	.	.	PUNCT
iajs-801	38	1	many	many	ADJ
iajs-801	38	2	reportes	reporte	NOUN
iajs-801	38	3	showed	show	VERB
iajs-801	38	4	that	that	SCONJ
iajs-801	38	5	diabetic	diabetic	ADJ
iajs-801	38	6	humans	human	NOUN
iajs-801	38	7	have	have	AUX
iajs-801	38	8	shown	show	VERB
iajs-801	38	9	increased	increase	VERB
iajs-801	38	10	lipid	lipid	NOUN
iajs-801	38	11	peroxidation	peroxidation	NOUN
iajs-801	38	12	and	and	CCONJ
iajs-801	38	13	decreased	decrease	VERB
iajs-801	38	14	levels	level	NOUN
iajs-801	38	15	of	of	ADP
iajs-801	38	16	reduced	reduced	ADJ
iajs-801	38	17	glutathione	glutathione	NOUN
iajs-801	38	18	and	and	CCONJ
iajs-801	38	19	these	these	DET
iajs-801	38	20	results	result	NOUN
iajs-801	38	21	suggest	suggest	VERB
iajs-801	38	22	that	that	SCONJ
iajs-801	38	23	the	the	DET
iajs-801	38	24	increase	increase	NOUN
iajs-801	38	25	in	in	ADP
iajs-801	38	26	lipid	lipid	NOUN
iajs-801	38	27	peroxidation	peroxidation	NOUN
iajs-801	38	28	,	,	PUNCT
iajs-801	38	29	and	and	CCONJ
iajs-801	38	30	the	the	DET
iajs-801	38	31	decline	decline	NOUN
iajs-801	38	32	in	in	ADP
iajs-801	38	33	antioxidant	antioxidant	ADJ
iajs-801	38	34	defences	defence	NOUN
iajs-801	38	35	may	may	AUX
iajs-801	38	36	appear	appear	VERB
iajs-801	38	37	early	early	ADV
iajs-801	38	38	in	in	ADP
iajs-801	38	39	type	type	NOUN
iajs-801	38	40	2	2	NUM
iajs-801	38	41	non	non	ADJ
iajs-801	38	42	-	-	ADJ
iajs-801	38	43	insulin	insulin	ADJ
iajs-801	38	44	dependent	dependent	ADJ
iajs-801	38	45	diabetes	diabetes	NOUN
iajs-801	38	46	mellitus	mellitus	NOUN
iajs-801	38	47	patients	patient	NOUN
iajs-801	38	48	,	,	PUNCT
iajs-801	38	49	before	before	ADP
iajs-801	38	50	the	the	DET
iajs-801	38	51	development	development	NOUN
iajs-801	38	52	of	of	ADP
iajs-801	38	53	secondary	secondary	ADJ
iajs-801	38	54	complications	complication	NOUN
iajs-801	38	55	[	[	X
iajs-801	38	56	11,12	11,12	NUM
iajs-801	38	57	]	]	PUNCT
iajs-801	38	58	.	.	PUNCT
iajs-801	39	1	α1	α1	PROPN
iajs-801	39	2	-	-	PUNCT
iajs-801	39	3	antitrypsine	antitrypsine	NOUN
iajs-801	39	4	:	:	PUNCT
iajs-801	39	5	a	a	DET
iajs-801	39	6	significant	significant	ADJ
iajs-801	39	7	increase	increase	NOUN
iajs-801	39	8	in	in	ADP
iajs-801	39	9	α1	α1	PROPN
iajs-801	39	10	-	-	PUNCT
iajs-801	39	11	antitrypsine	antitrypsine	NOUN
iajs-801	39	12	levels	level	NOUN
iajs-801	39	13	was	be	AUX
iajs-801	39	14	found	find	VERB
iajs-801	39	15	between	between	ADP
iajs-801	39	16	dm	dm	PROPN
iajs-801	39	17	patients	patient	NOUN
iajs-801	39	18	which	which	PRON
iajs-801	39	19	was	be	AUX
iajs-801	39	20	1877.11	1877.11	NUM
iajs-801	39	21	±	±	NUM
iajs-801	39	22	222.889	222.889	NUM
iajs-801	39	23	mg	mg	NOUN
iajs-801	39	24	/	/	SYM
iajs-801	39	25	l	l	NOUN
iajs-801	39	26	compared	compare	VERB
iajs-801	39	27	with	with	ADP
iajs-801	39	28	healthy	healthy	ADJ
iajs-801	39	29	control	control	NOUN
iajs-801	39	30	which	which	PRON
iajs-801	39	31	was	be	AUX
iajs-801	39	32	950.00	950.00	NUM
iajs-801	39	33	±	±	NUM
iajs-801	39	34	104.88	104.88	NUM
iajs-801	39	35	mg	mg	PROPN
iajs-801	39	36	/	/	SYM
iajs-801	39	37	l	l	NOUN
iajs-801	39	38	the	the	DET
iajs-801	39	39	results	result	NOUN
iajs-801	39	40	of	of	ADP
iajs-801	39	41	the	the	DET
iajs-801	39	42	present	present	ADJ
iajs-801	39	43	study	study	NOUN
iajs-801	39	44	is	be	AUX
iajs-801	39	45	in	in	ADP
iajs-801	39	46	agreement	agreement	NOUN
iajs-801	39	47	with	with	ADP
iajs-801	39	48	reported	report	VERB
iajs-801	39	49	data	datum	NOUN
iajs-801	39	50	claimed	claim	VERB
iajs-801	39	51	an	an	DET
iajs-801	39	52	increase	increase	NOUN
iajs-801	39	53	in	in	ADP
iajs-801	39	54	the	the	DET
iajs-801	39	55	levels	level	NOUN
iajs-801	39	56	of	of	ADP
iajs-801	39	57	acute	acute	ADJ
iajs-801	39	58	-	-	PUNCT
iajs-801	39	59	phase	phase	NOUN
iajs-801	39	60	protein	protein	NOUN
iajs-801	39	61	including	include	VERB
iajs-801	39	62	α1	α1	NOUN
iajs-801	39	63	-	-	PUNCT
iajs-801	39	64	antitrypsine	antitrypsine	NOUN
iajs-801	39	65	in	in	ADP
iajs-801	39	66	adult	adult	NOUN
iajs-801	39	67	diabetes	diabetes	NOUN
iajs-801	39	68	(	(	PUNCT
iajs-801	39	69	principally	principally	ADV
iajs-801	39	70	type	type	NOUN
iajs-801	39	71	(	(	PUNCT
iajs-801	39	72	2	2	NUM
iajs-801	39	73	)	)	PUNCT
iajs-801	39	74	)	)	PUNCT
iajs-801	40	1	[	[	X
iajs-801	40	2	13	13	NUM
iajs-801	40	3	]	]	PUNCT
iajs-801	40	4	,	,	PUNCT
iajs-801	40	5	also	also	ADV
iajs-801	40	6	results	result	VERB
iajs-801	40	7	proposed	propose	VERB
iajs-801	40	8	a	a	DET
iajs-801	40	9	novel	novel	ADJ
iajs-801	40	10	biological	biological	ADJ
iajs-801	40	11	function	function	NOUN
iajs-801	40	12	for	for	ADP
iajs-801	40	13	α1	α1	NOUN
iajs-801	40	14	-	-	PUNCT
iajs-801	40	15	antitrypsine	antitrypsine	NOUN
iajs-801	40	16	and	and	CCONJ
iajs-801	40	17	suggest	suggest	VERB
iajs-801	40	18	that	that	SCONJ
iajs-801	40	19	it	it	PRON
iajs-801	40	20	may	may	AUX
iajs-801	40	21	represent	represent	VERB
iajs-801	40	22	an	an	DET
iajs-801	40	23	effective	effective	ADJ
iajs-801	40	24	candidate	candidate	NOUN
iajs-801	40	25	for	for	ADP
iajs-801	40	26	attempts	attempt	NOUN
iajs-801	40	27	seeking	seek	VERB
iajs-801	40	28	to	to	PART
iajs-801	40	29	prevent	prevent	VERB
iajs-801	40	30	or	or	CCONJ
iajs-801	40	31	reverse	reverse	ADJ
iajs-801	40	32	type	type	NOUN
iajs-801	40	33	1	1	NUM
iajs-801	40	34	diabetes	diabetes	NOUN
iajs-801	40	35	[	[	X
iajs-801	40	36	14	14	NUM
iajs-801	40	37	]	]	PUNCT
iajs-801	40	38	.	.	PUNCT
iajs-801	41	1	on	on	ADP
iajs-801	41	2	the	the	DET
iajs-801	41	3	other	other	ADJ
iajs-801	41	4	,	,	PUNCT
iajs-801	41	5	a	a	DET
iajs-801	41	6	study	study	NOUN
iajs-801	41	7	is	be	AUX
iajs-801	41	8	on	on	ADP
iajs-801	41	9	α1	α1	NOUN
iajs-801	41	10	-	-	PUNCT
iajs-801	41	11	antitrypsine	antitrypsine	NOUN
iajs-801	41	12	in	in	ADP
iajs-801	41	13	diabetes	diabetes	NOUN
iajs-801	41	14	in	in	ADP
iajs-801	41	15	both	both	PRON
iajs-801	41	16	.	.	PUNCT
iajs-801	42	1	type	type	NOUN
iajs-801	42	2	i	i	PROPN
iajs-801	42	3	and	and	CCONJ
iajs-801	42	4	ii	ii	PROPN
iajs-801	42	5	diabetes	diabetes	NOUN
iajs-801	42	6	mellitus	mellitus	NOUN
iajs-801	42	7	are	be	AUX
iajs-801	42	8	associated	associate	VERB
iajs-801	42	9	with	with	ADP
iajs-801	42	10	reduced	reduced	ADJ
iajs-801	42	11	α1	α1	PROPN
iajs-801	42	12	-	-	PUNCT
iajs-801	42	13	antitrypsine	antitrypsine	NOUN
iajs-801	42	14	as	as	ADP
iajs-801	42	15	serine	serine	ADJ
iajs-801	42	16	protease	protease	NOUN
iajs-801	42	17	inhibitory	inhibitory	ADJ
iajs-801	42	18	capacity	capacity	NOUN
iajs-801	42	19	of	of	ADP
iajs-801	42	20	plasma	plasma	NOUN
iajs-801	42	21	[	[	X
iajs-801	42	22	15	15	NUM
iajs-801	42	23	]	]	PUNCT
iajs-801	42	24	.	.	PUNCT
iajs-801	43	1	fig	fig	NOUN
iajs-801	43	2	(	(	PUNCT
iajs-801	43	3	1	1	X
iajs-801	43	4	)	)	PUNCT
iajs-801	43	5	shows	show	VERB
iajs-801	43	6	correlation	correlation	NOUN
iajs-801	43	7	relation	relation	NOUN
iajs-801	43	8	between	between	ADP
iajs-801	43	9	α1	α1	PROPN
iajs-801	43	10	-	-	PUNCT
iajs-801	43	11	antitrypsine	antitrypsine	NOUN
iajs-801	43	12	and	and	CCONJ
iajs-801	43	13	reduced	reduce	VERB
iajs-801	43	14	glutathione	glutathione	NOUN
iajs-801	43	15	for	for	ADP
iajs-801	43	16	dm	dm	PROPN
iajs-801	43	17	type	type	NOUN
iajs-801	43	18	ii	ii	NOUN
iajs-801	43	19	patients	patient	NOUN
iajs-801	43	20	and	and	CCONJ
iajs-801	43	21	healthy	healthy	ADJ
iajs-801	43	22	control	control	NOUN
iajs-801	43	23	.	.	PUNCT
iajs-801	44	1	the	the	DET
iajs-801	44	2	correlation	correlation	NOUN
iajs-801	44	3	was	be	AUX
iajs-801	44	4	found	find	VERB
iajs-801	44	5	to	to	PART
iajs-801	44	6	be	be	AUX
iajs-801	44	7	(	(	PUNCT
iajs-801	44	8	+	+	NOUN
iajs-801	44	9	ve	ve	VERB
iajs-801	44	10	)	)	PUNCT
iajs-801	44	11	for	for	ADP
iajs-801	44	12	dmii	dmii	NOUN
iajs-801	44	13	patients	patient	NOUN
iajs-801	44	14	and	and	CCONJ
iajs-801	44	15	(	(	PUNCT
iajs-801	44	16	-ve	-ve	NOUN
iajs-801	44	17	)	)	PUNCT
iajs-801	44	18	for	for	ADP
iajs-801	44	19	healthy	healthy	ADJ
iajs-801	44	20	control	control	NOUN
iajs-801	44	21	with	with	ADP
iajs-801	44	22	r	r	NOUN
iajs-801	44	23	values	value	NOUN
iajs-801	44	24	0.257	0.257	NUM
iajs-801	44	25	and	and	CCONJ
iajs-801	44	26	-0.339	-0.339	NOUN
iajs-801	44	27	respectively	respectively	ADV
iajs-801	44	28	.	.	PUNCT
iajs-801	45	1	references	reference	NOUN
iajs-801	45	2	1	1	NUM
iajs-801	45	3	shiranda	shiranda	PROPN
iajs-801	45	4	,	,	PUNCT
iajs-801	45	5	n.b	n.b	PROPN
iajs-801	45	6	.	.	PROPN
iajs-801	45	7	(	(	PUNCT
iajs-801	45	8	2008	2008	NUM
iajs-801	45	9	)	)	PUNCT
iajs-801	45	10	,	,	PUNCT
iajs-801	45	11	"	"	PUNCT
iajs-801	45	12	manipal	manipal	NOUN
iajs-801	45	13	manual	manual	NOUN
iajs-801	45	14	of	of	ADP
iajs-801	45	15	clinical	clinical	ADJ
iajs-801	45	16	biochemistry	biochemistry	NOUN
iajs-801	45	17	"	"	PUNCT
iajs-801	45	18	,	,	PUNCT
iajs-801	45	19	new	new	ADJ
iajs-801	45	20	delhi	delhi	PROPN
iajs-801	45	21	;	;	PUNCT
iajs-801	45	22	3rd	3rd	ADJ
iajs-801	45	23	edition	edition	NOUN
iajs-801	45	24	,	,	PUNCT
iajs-801	45	25	jaypee	jaypee	PROPN
iajs-801	45	26	brothers	brothers	PROPN
iajs-801	45	27	medical	medical	ADJ
iajs-801	45	28	publishers	publisher	NOUN
iajs-801	45	29	(	(	PUNCT
iajs-801	45	30	p	p	X
iajs-801	45	31	)	)	PUNCT
iajs-801	45	32	ltd	ltd	PROPN
iajs-801	45	33	,	,	PUNCT
iajs-801	45	34	p70	p70	PROPN
iajs-801	45	35	.	.	PROPN
iajs-801	45	36	2	2	NUM
iajs-801	45	37	shweta	shweta	PROPN
iajs-801	45	38	,	,	PUNCT
iajs-801	45	39	b.	b.	PROPN
iajs-801	45	40	;	;	PUNCT
iajs-801	45	41	rimi	rimi	PROPN
iajs-801	45	42	,	,	PUNCT
iajs-801	45	43	s.	s.	PROPN
iajs-801	45	44	and	and	CCONJ
iajs-801	45	45	sriv	sriv	PROPN
iajs-801	45	46	,	,	PUNCT
iajs-801	45	47	(	(	PUNCT
iajs-801	45	48	2003	2003	NUM
iajs-801	45	49	)	)	PUNCT
iajs-801	45	50	"	"	PUNCT
iajs-801	45	51	clinical	clinical	ADJ
iajs-801	45	52	biochemistry	biochemistry	NOUN
iajs-801	45	53	v.36	v.36	NOUN
iajs-801	45	54	:	:	PUNCT
iajs-801	45	55	issue	issue	NOUN
iajs-801	45	56	7	7	NUM
iajs-801	45	57	.	.	SYM
iajs-801	45	58	3	3	NUM
iajs-801	45	59	robert	robert	PROPN
iajs-801	45	60	,	,	PUNCT
iajs-801	45	61	k.	k.	PROPN
iajs-801	45	62	;	;	PUNCT
iajs-801	45	63	murray	murray	PROPN
iajs-801	45	64	,	,	PUNCT
iajs-801	45	65	;	;	PUNCT
iajs-801	45	66	daryl	daryl	PROPN
iajs-801	45	67	,	,	PUNCT
iajs-801	45	68	k.	k.	PROPN
iajs-801	45	69	granner	granner	PROPN
iajs-801	45	70	and	and	CCONJ
iajs-801	45	71	victor	victor	PROPN
iajs-801	45	72	,	,	PUNCT
iajs-801	45	73	w.	w.	PROPN
iajs-801	45	74	rodwell	rodwell	PROPN
iajs-801	45	75	(	(	PUNCT
iajs-801	45	76	2006	2006	NUM
iajs-801	45	77	)	)	PUNCT
iajs-801	45	78	"	"	PUNCT
iajs-801	45	79	harper	harper	NOUN
iajs-801	45	80	's	's	PART
iajs-801	45	81	illustrated	illustrate	VERB
iajs-801	45	82	biochemistry	biochemistry	NOUN
iajs-801	45	83	"	"	PUNCT
iajs-801	45	84	27	27	NUM
iajs-801	45	85	th	th	X
iajs-801	45	86	edition	edition	NOUN
iajs-801	45	87	.	.	PUNCT
iajs-801	46	1	mc	mc	PROPN
iajs-801	46	2	graw	graw	PROPN
iajs-801	46	3	hill	hill	PROPN
iajs-801	46	4	,	,	PUNCT
iajs-801	46	5	new	new	PROPN
iajs-801	46	6	york	york	PROPN
iajs-801	46	7	chicago	chicago	PROPN
iajs-801	46	8	,	,	PUNCT
iajs-801	46	9	p636	p636	PROPN
iajs-801	46	10	.	.	NOUN
iajs-801	46	11	4	4	NUM
iajs-801	46	12	gabay	gabay	NOUN
iajs-801	46	13	,	,	PUNCT
iajs-801	46	14	c.	c.	PROPN
iajs-801	46	15	and	and	CCONJ
iajs-801	46	16	kushner	kushner	PROPN
iajs-801	46	17	,	,	PUNCT
iajs-801	46	18	i.	i.	PROPN
iajs-801	46	19	(	(	PUNCT
iajs-801	46	20	1999	1999	NUM
iajs-801	46	21	)	)	PUNCT
iajs-801	46	22	acute	acute	NOUN
iajs-801	46	23	phase	phase	NOUN
iajs-801	46	24	proteins	protein	NOUN
iajs-801	46	25	and	and	CCONJ
iajs-801	46	26	other	other	ADJ
iajs-801	46	27	systemic	systemic	ADJ
iajs-801	46	28	responses	response	NOUN
iajs-801	46	29	to	to	PART
iajs-801	46	30	inflammationn	inflammationn	VERB
iajs-801	46	31	engl	engl	PROPN
iajs-801	46	32	j	j	PROPN
iajs-801	46	33	"	"	PUNCT
iajs-801	46	34	med	med	PROPN
iajs-801	46	35	.	.	PUNCT
iajs-801	47	1	v.	v.	ADP
iajs-801	47	2	340	340	NUM
iajs-801	47	3	:	:	PUNCT
iajs-801	47	4	issue	issue	NOUN
iajs-801	47	5	448	448	NUM
iajs-801	47	6	.	.	SYM
iajs-801	47	7	5	5	NUM
iajs-801	47	8	liyp	liyp	PROPN
iajs-801	47	9	,	,	PUNCT
iajs-801	47	10	schwartz	schwartz	PROPN
iajs-801	47	11	,	,	PUNCT
iajs-801	47	12	r.j	r.j	PROPN
iajs-801	47	13	.	.	PROPN
iajs-801	47	14	and	and	CCONJ
iajs-801	47	15	waddell	waddell	PROPN
iajs-801	47	16	,	,	PUNCT
iajs-801	47	17	i.d	i.d	PROPN
iajs-801	47	18	.	.	PROPN
iajs-801	48	1	(	(	PUNCT
iajs-801	48	2	1998	1998	NUM
iajs-801	48	3	)	)	PUNCT
iajs-801	48	4	,	,	PUNCT
iajs-801	48	5	skeletal	skeletal	ADJ
iajs-801	48	6	muscle	muscle	NOUN
iajs-801	48	7	myocytes	myocyte	NOUN
iajs-801	48	8	undergo	undergo	VERB
iajs-801	48	9	protein	protein	NOUN
iajs-801	48	10	loss	loss	NOUN
iajs-801	48	11	and	and	CCONJ
iajs-801	48	12	reactive	reactive	ADJ
iajs-801	48	13	oxygen	oxygen	NOUN
iajs-801	48	14	-	-	PUNCT
iajs-801	48	15	mediated	mediate	VERB
iajs-801	48	16	nf	nf	NOUN
iajs-801	48	17	-	-	PUNCT
iajs-801	48	18	kappa	kappa	NOUN
iajs-801	48	19	b	b	NOUN
iajs-801	48	20	activation	activation	NOUN
iajs-801	48	21	in	in	ADP
iajs-801	48	22	response	response	NOUN
iajs-801	48	23	to	to	ADP
iajs-801	48	24	tumor	tumor	NOUN
iajs-801	48	25	necrosis	necrosis	NOUN
iajs-801	48	26	factor	factor	NOUN
iajs-801	48	27	alpha	alpha	PROPN
iajs-801	48	28	.	.	PUNCT
iajs-801	49	1	faseb	faseb	PROPN
iajs-801	49	2	j:12:871	j:12:871	PROPN
iajs-801	49	3	.	.	PUNCT
iajs-801	50	1	6	6	NUM
iajs-801	50	2	ellman	ellman	NOUN
iajs-801	50	3	,	,	PUNCT
iajs-801	50	4	g.l	g.l	PROPN
iajs-801	50	5	.	.	PROPN
iajs-801	50	6	(	(	PUNCT
iajs-801	50	7	1959	1959	NUM
iajs-801	50	8	):	):	PUNCT
iajs-801	50	9	arch	arch	NOUN
iajs-801	50	10	-	-	PUNCT
iajs-801	50	11	biochem	biochem	NOUN
iajs-801	50	12	.	.	PUNCT
iajs-801	51	1	biophys	biophy	NOUN
iajs-801	51	2	82:70	82:70	NUM
iajs-801	51	3	-	-	SYM
iajs-801	51	4	77	77	NUM
iajs-801	51	5	.	.	NOUN
iajs-801	51	6	7	7	NUM
iajs-801	51	7	protein	protein	NOUN
iajs-801	51	8	reference	reference	NOUN
iajs-801	51	9	unit	unit	NOUN
iajs-801	51	10	hand	hand	NOUN
iajs-801	51	11	book	book	NOUN
iajs-801	51	12	of	of	ADP
iajs-801	51	13	clinical	clinical	ADJ
iajs-801	51	14	immuno	immuno	ADJ
iajs-801	51	15	chemistry	chemistry	NOUN
iajs-801	51	16	.	.	PUNCT
iajs-801	52	1	(	(	PUNCT
iajs-801	52	2	1990	1990	NUM
iajs-801	52	3	)	)	PUNCT
iajs-801	52	4	,	,	PUNCT
iajs-801	52	5	ed	ed	NOUN
iajs-801	52	6	,	,	PUNCT
iajs-801	52	7	amilford	amilford	PROPN
iajs-801	52	8	ibn	ibn	PROPN
iajs-801	52	9	alhaitham	alhaitham	PROPN
iajs-801	52	10	j.	j.	PROPN
iajs-801	52	11	for	for	ADP
iajs-801	52	12	pure	pure	ADJ
iajs-801	52	13	&	&	CCONJ
iajs-801	52	14	appl	appl	PROPN
iajs-801	52	15	.	.	PUNCT
iajs-801	53	1	sci	sci	PROPN
iajs-801	53	2	.	.	PUNCT
iajs-801	53	3	vol.24	vol.24	NOUN
iajs-801	53	4	(	(	PUNCT
iajs-801	53	5	1	1	NUM
iajs-801	53	6	)	)	PUNCT
iajs-801	53	7	2011	2011	NUM
iajs-801	53	8	word	word	NOUN
iajs-801	53	9	,	,	PUNCT
iajs-801	53	10	publ	publ	NOUN
iajs-801	53	11	,	,	PUNCT
iajs-801	53	12	publ	publ	NOUN
iajs-801	53	13	.	.	PUNCT
iajs-801	54	1	pru	pru	PROPN
iajs-801	54	2	publication	publication	NOUN
iajs-801	54	3	sheffie	sheffie	PROPN
iajs-801	54	4	.	.	PUNCT
iajs-801	55	1	d.63	d.63	PROPN
iajs-801	55	2	-	-	PROPN
iajs-801	55	3	65	65	NUM
iajs-801	55	4	.	.	NOUN
iajs-801	55	5	8	8	NUM
iajs-801	55	6	nwcke	nwcke	NOUN
iajs-801	55	7	,	,	PUNCT
iajs-801	55	8	n.	n.	NOUN
iajs-801	55	9	;	;	PUNCT
iajs-801	55	10	cohari	cohari	PROPN
iajs-801	55	11	,	,	PUNCT
iajs-801	55	12	c.	c.	PROPN
iajs-801	55	13	obioma	obioma	PROPN
iajs-801	55	14	and	and	CCONJ
iajs-801	55	15	cezeala	cezeala	PROPN
iajs-801	55	16	,	,	PUNCT
iajs-801	55	17	c.	c.	PROPN
iajs-801	55	18	chinyere	chinyere	NOUN
iajs-801	55	19	.	.	PUNCT
iajs-801	56	1	(	(	PUNCT
iajs-801	56	2	2009	2009	NUM
iajs-801	56	3	)	)	PUNCT
iajs-801	56	4	"	"	PUNCT
iajs-801	56	5	effect	effect	NOUN
iajs-801	56	6	of	of	ADP
iajs-801	56	7	vitamin	vitamin	NOUN
iajs-801	56	8	on	on	ADP
iajs-801	56	9	malondialdehyde	malondialdehyde	NOUN
iajs-801	56	10	and	and	CCONJ
iajs-801	56	11	glutathione	glutathione	NOUN
iajs-801	56	12	levels	level	NOUN
iajs-801	56	13	in	in	ADP
iajs-801	56	14	type	type	NOUN
iajs-801	56	15	2	2	NUM
iajs-801	56	16	diabetic	diabetic	ADJ
iajs-801	56	17	nigerians	nigerians	PROPN
iajs-801	56	18	,	,	PUNCT
iajs-801	56	19	internet	internet	NOUN
iajs-801	56	20	journal	journal	NOUN
iajs-801	56	21	of	of	ADP
iajs-801	56	22	pharmacology	pharmacology	NOUN
iajs-801	56	23	volume	volume	NOUN
iajs-801	56	24	7	7	NUM
iajs-801	56	25	number1	number1	NOUN
iajs-801	56	26	.	.	PROPN
iajs-801	56	27	9	9	NUM
iajs-801	56	28	lee	lee	PROPN
iajs-801	56	29	ay	ay	PROPN
iajs-801	56	30	and	and	CCONJ
iajs-801	56	31	chung	chung	PROPN
iajs-801	56	32	,	,	PUNCT
iajs-801	56	33	s.s	s.s	PROPN
iajs-801	56	34	;	;	PUNCT
iajs-801	56	35	(	(	PUNCT
iajs-801	56	36	1999	1999	NUM
iajs-801	56	37	)	)	PUNCT
iajs-801	56	38	;	;	PUNCT
iajs-801	56	39	"	"	PUNCT
iajs-801	56	40	contrrbutrons	contrrbutron	NOUN
iajs-801	56	41	of	of	ADP
iajs-801	56	42	polyol	polyol	NOUN
iajs-801	56	43	pathway	pathway	NOUN
iajs-801	56	44	to	to	PART
iajs-801	56	45	oxidative	oxidative	VERB
iajs-801	56	46	stress	stress	NOUN
iajs-801	56	47	in	in	ADP
iajs-801	56	48	diabetrc	diabetrc	ADJ
iajs-801	56	49	cataract	cataract	NOUN
iajs-801	56	50	"	"	PUNCT
iajs-801	56	51	.	.	PUNCT
iajs-801	57	1	faseb	faseb	PROPN
iajs-801	57	2	j.	j.	PROPN
iajs-801	57	3	;	;	PUNCT
iajs-801	57	4	13:23	13:23	NUM
iajs-801	57	5	-	-	SYM
iajs-801	57	6	30	30	NUM
iajs-801	57	7	.	.	PUNCT
iajs-801	58	1	10	10	NUM
iajs-801	58	2	paolisso	paolisso	NOUN
iajs-801	58	3	,	,	PUNCT
iajs-801	58	4	g.	g.	PROPN
iajs-801	58	5	d.	d.	PROPN
iajs-801	58	6	;	;	PUNCT
iajs-801	58	7	maro	maro	PROPN
iajs-801	58	8	,	,	PUNCT
iajs-801	58	9	d.	d.	PROPN
iajs-801	58	10	and	and	CCONJ
iajs-801	58	11	pizza	pizza	PROPN
iajs-801	58	12	,	,	PUNCT
iajs-801	58	13	g.	g.	PROPN
iajs-801	58	14	d.	d.	PROPN
iajs-801	58	15	(	(	PUNCT
iajs-801	58	16	1992	1992	NUM
iajs-801	58	17	)	)	PUNCT
iajs-801	58	18	plasma	plasma	NOUN
iajs-801	58	19	gsh	gsh	PROPN
iajs-801	58	20	/	/	SYM
iajs-801	58	21	gssh	gssh	PROPN
iajs-801	58	22	affects	affect	VERB
iajs-801	58	23	glucose	glucose	NOUN
iajs-801	58	24	none	none	NOUN
iajs-801	58	25	ostasis	ostasis	NOUN
iajs-801	58	26	in	in	ADP
iajs-801	58	27	healthy	healthy	ADJ
iajs-801	58	28	subjects	subject	NOUN
iajs-801	58	29	and	and	CCONJ
iajs-801	58	30	non	non	ADJ
iajs-801	58	31	-	-	ADJ
iajs-801	58	32	insulin	insulin	ADJ
iajs-801	58	33	dependent	dependent	ADJ
iajs-801	58	34	diabetics	diabetic	NOUN
iajs-801	58	35	.	.	PUNCT
iajs-801	59	1	american	american	ADJ
iajs-801	59	2	journal	journal	PROPN
iajs-801	59	3	of	of	ADP
iajs-801	59	4	physiology	physiology	NOUN
iajs-801	59	5	;	;	PUNCT
iajs-801	59	6	263:435	263:435	PROPN
iajs-801	59	7	-	-	PUNCT
iajs-801	59	8	440	440	NUM
iajs-801	59	9	.	.	PUNCT
iajs-801	59	10	11	11	NUM
iajs-801	59	11	sailaja	sailaja	NOUN
iajs-801	59	12	,	,	PUNCT
iajs-801	59	13	y.r	y.r	PROPN
iajs-801	59	14	.	.	PROPN
iajs-801	59	15	;	;	PUNCT
iajs-801	59	16	baskar	baskar	PROPN
iajs-801	59	17	,	,	PUNCT
iajs-801	59	18	r.	r.	PROPN
iajs-801	59	19	and	and	CCONJ
iajs-801	59	20	saralaku	saralaku	PROPN
iajs-801	59	21	mari	mari	PROPN
iajs-801	59	22	,	,	PUNCT
iajs-801	59	23	d.	d.	PROPN
iajs-801	59	24	(	(	PUNCT
iajs-801	59	25	2003	2003	NUM
iajs-801	59	26	)	)	PUNCT
iajs-801	59	27	the	the	DET
iajs-801	59	28	antioxidant	antioxidant	ADJ
iajs-801	59	29	erythrocytes	erythrocyte	NOUN
iajs-801	59	30	in	in	ADP
iajs-801	59	31	type2	type2	PROPN
iajs-801	59	32	diabeties	diabetie	NOUN
iajs-801	59	33	free	free	ADJ
iajs-801	59	34	radical	radical	ADJ
iajs-801	59	35	biol	biol	NOUN
iajs-801	59	36	med	me	VERB
iajs-801	59	37	;	;	PUNCT
iajs-801	59	38	35:133	35:133	NUM
iajs-801	59	39	-	-	SYM
iajs-801	59	40	139	139	NUM
iajs-801	59	41	.	.	PUNCT
iajs-801	60	1	12	12	NUM
iajs-801	60	2	mahbob	mahbob	ADJ
iajs-801	60	3	,	,	PUNCT
iajs-801	60	4	m.	m.	NOUN
iajs-801	60	5	;	;	PUNCT
iajs-801	60	6	rahman	rahman	PROPN
iajs-801	60	7	,	,	PUNCT
iajs-801	60	8	m.	m.	PROPN
iajs-801	60	9	f.	f.	PROPN
iajs-801	60	10	and	and	CCONJ
iajs-801	60	11	grover	grover	PROPN
iajs-801	60	12	,	,	PUNCT
iajs-801	60	13	p.	p.	NOUN
iajs-801	60	14	(	(	PUNCT
iajs-801	60	15	2005	2005	NUM
iajs-801	60	16	)	)	PUNCT
iajs-801	60	17	serum	serum	NOUN
iajs-801	60	18	lipid	lipid	NOUN
iajs-801	60	19	peroxidation	peroxidation	NOUN
iajs-801	60	20	and	and	CCONJ
iajs-801	60	21	antioxidant	antioxidant	ADJ
iajs-801	60	22	enzyme	enzyme	NOUN
iajs-801	60	23	levels	level	NOUN
iajs-801	60	24	in	in	ADP
iajs-801	60	25	male	male	ADJ
iajs-801	60	26	and	and	CCONJ
iajs-801	60	27	female	female	ADJ
iajs-801	60	28	diabetic	diabetic	ADJ
iajs-801	60	29	patients	patient	NOUN
iajs-801	60	30	singapore	singapore	PROPN
iajs-801	60	31	.	.	PUNCT
iajs-801	61	1	med	med	PROPN
iajs-801	61	2	j	j	PROPN
iajs-801	61	3	;	;	PUNCT
iajs-801	61	4	46(7):322	46(7):322	PROPN
iajs-801	61	5	.	.	PROPN
iajs-801	61	6	13	13	NUM
iajs-801	61	7	millon	millon	NOUN
iajs-801	61	8	,	,	PUNCT
iajs-801	61	9	m.c	m.c	PROPN
iajs-801	61	10	.	.	PROPN
iajs-801	61	11	d.e	d.e	PROPN
iajs-801	61	12	.	.	PUNCT
iajs-801	62	1	(	(	PUNCT
iajs-801	62	2	1989	1989	NUM
iajs-801	62	3	)	)	PUNCT
iajs-801	62	4	;	;	PUNCT
iajs-801	63	1	increased	increase	VERB
iajs-801	63	2	levels	level	NOUN
iajs-801	63	3	of	of	ADP
iajs-801	63	4	acute	acute	ADJ
iajs-801	63	5	phase	phase	NOUN
iajs-801	63	6	serum	serum	NOUN
iajs-801	63	7	proteins	protein	NOUN
iajs-801	63	8	in	in	ADP
iajs-801	63	9	diabetes	diabetes	NOUN
iajs-801	63	10	;	;	PUNCT
iajs-801	63	11	pub	pub	NOUN
iajs-801	63	12	med	me	VERB
iajs-801	63	13	j.	j.	PROPN
iajs-801	63	14	38(ii	38(ii	NUM
iajs-801	63	15	):	):	PUNCT
iajs-801	63	16	1042	1042	NUM
iajs-801	63	17	-	-	SYM
iajs-801	63	18	1046	1046	NUM
iajs-801	63	19	.	.	PUNCT
iajs-801	64	1	14	14	NUM
iajs-801	64	2	bin	bin	NOUN
iajs-801	64	3	,	,	PUNCT
iajs-801	64	4	z.	z.	PROPN
iajs-801	64	5	;	;	PUNCT
iajs-801	64	6	ymanging	ymange	VERB
iajs-801	64	7	,	,	PUNCT
iajs-801	64	8	l.u	l.u	PROPN
iajs-801	64	9	.	.	PROPN
iajs-801	64	10	and	and	CCONJ
iajs-801	64	11	marth	marth	PROPN
iajs-801	64	12	compbell	compbell	PROPN
iajs-801	64	13	;	;	PUNCT
iajs-801	64	14	(	(	PUNCT
iajs-801	64	15	2007	2007	NUM
iajs-801	64	16	)	)	PUNCT
iajs-801	64	17	alpha	alpha	NOUN
iajs-801	64	18	1	1	NUM
iajs-801	64	19	antitrypsin	antitrypsin	NOUN
iajs-801	64	20	protects	protect	VERB
iajs-801	64	21	β	β	NOUN
iajs-801	64	22	-	-	NOUN
iajs-801	64	23	cells	cell	NOUN
iajs-801	64	24	from	from	ADP
iajs-801	64	25	apoptosis	apoptosis	NOUN
iajs-801	64	26	;	;	PUNCT
iajs-801	64	27	published	publish	VERB
iajs-801	64	28	online	online	ADJ
iajs-801	64	29	march	march	PROPN
iajs-801	64	30	14	14	NUM
iajs-801	64	31	.	.	NOUN
iajs-801	64	32	15	15	NUM
iajs-801	64	33	hashemi	hashemi	NOUN
iajs-801	64	34	,	,	PUNCT
iajs-801	64	35	m.	m.	NOUN
iajs-801	64	36	;	;	PUNCT
iajs-801	64	37	naderi	naderi	ADJ
iajs-801	64	38	.	.	PUNCT
iajs-801	65	1	m.	m.	NOUN
iajs-801	65	2	and	and	CCONJ
iajs-801	65	3	rashidi	rashidi	PROPN
iajs-801	65	4	(	(	PUNCT
iajs-801	65	5	2007	2007	NUM
iajs-801	65	6	)	)	PUNCT
iajs-801	65	7	diabetes	diabetes	NOUN
iajs-801	65	8	res	re	NOUN
iajs-801	65	9	;	;	PUNCT
iajs-801	65	10	clinical	clinical	ADJ
iajs-801	65	11	pract	pract	NOUN
iajs-801	65	12	;	;	PUNCT
iajs-801	65	13	75(2):246	75(2):246	NUM
iajs-801	65	14	-	-	PUNCT
iajs-801	65	15	248	248	NUM
iajs-801	65	16	.	.	PUNCT
iajs-801	66	1	table(1	table(1	PROPN
iajs-801	66	2	):	):	PUNCT
iajs-801	66	3	shows	show	VERB
iajs-801	66	4	the	the	DET
iajs-801	66	5	level	level	NOUN
iajs-801	66	6	,	,	PUNCT
iajs-801	66	7	mean	mean	NOUN
iajs-801	66	8	and	and	CCONJ
iajs-801	66	9	sd	sd	NOUN
iajs-801	66	10	of	of	ADP
iajs-801	66	11	reduced	reduced	ADJ
iajs-801	66	12	glutathione	glutathione	NOUN
iajs-801	66	13	in	in	ADP
iajs-801	66	14	sera	sera	NOUN
iajs-801	66	15	of	of	ADP
iajs-801	66	16	type	type	NOUN
iajs-801	66	17	2	2	NUM
iajs-801	66	18	dm	dm	NOUN
iajs-801	66	19	patient	patient	ADJ
iajs-801	66	20	and	and	CCONJ
iajs-801	66	21	healthy	healthy	ADJ
iajs-801	66	22	control	control	NOUN
iajs-801	66	23	gsh	gsh	PROPN
iajs-801	66	24	m	m	PROPN
iajs-801	66	25	n	n	ADV
iajs-801	66	26	mean	mean	VERB
iajs-801	66	27	sd	sd	ADP
iajs-801	66	28	p	p	NOUN
iajs-801	66	29	value	value	NOUN
iajs-801	66	30	patient	patient	NOUN
iajs-801	66	31	20	20	NUM
iajs-801	66	32	1.092	1.092	NUM
iajs-801	66	33	±	±	NUM
iajs-801	66	34	0.204	0.204	NUM
iajs-801	66	35	control	control	NOUN
iajs-801	66	36	10	10	NUM
iajs-801	66	37	3.400	3.400	NUM
iajs-801	66	38	±	±	NOUN
iajs-801	66	39	0.529	0.529	NUM
iajs-801	66	40	s	s	PART
iajs-801	66	41	:	:	PUNCT
iajs-801	66	42	significant	significant	ADJ
iajs-801	66	43	table(2	table(2	NOUN
iajs-801	66	44	):	):	PUNCT
iajs-801	66	45	shows	show	VERB
iajs-801	66	46	the	the	DET
iajs-801	66	47	level	level	NOUN
iajs-801	66	48	,	,	PUNCT
iajs-801	66	49	mean	mean	NOUN
iajs-801	66	50	and	and	CCONJ
iajs-801	66	51	sd	sd	NOUN
iajs-801	66	52	of	of	ADP
iajs-801	66	53	α1	α1	PROPN
iajs-801	66	54	–	–	PUNCT
iajs-801	66	55	antitrypsine	antitrypsine	NOUN
iajs-801	66	56	in	in	ADP
iajs-801	66	57	the	the	DET
iajs-801	66	58	sera	sera	NOUN
iajs-801	66	59	of	of	ADP
iajs-801	66	60	type	type	NOUN
iajs-801	66	61	2	2	NUM
iajs-801	66	62	dm	dm	NOUN
iajs-801	66	63	patient	patient	ADJ
iajs-801	66	64	and	and	CCONJ
iajs-801	66	65	healthy	healthy	ADJ
iajs-801	66	66	control	control	NOUN
iajs-801	66	67	α1	α1	PROPN
iajs-801	66	68	–	–	PUNCT
iajs-801	66	69	antitrypsin	antitrypsin	NOUN
iajs-801	66	70	mg	mg	PROPN
iajs-801	66	71	/	/	SYM
iajs-801	66	72	l	l	NOUN
iajs-801	66	73	n	n	ADV
iajs-801	66	74	mean	mean	VERB
iajs-801	66	75	sd	sd	ADP
iajs-801	66	76	p	p	NOUN
iajs-801	66	77	value	value	NOUN
iajs-801	66	78	patient	patient	NOUN
iajs-801	66	79	20	20	NUM
iajs-801	66	80	1877.111	1877.111	NUM
iajs-801	66	81	±	±	NUM
iajs-801	66	82	222.889	222.889	NUM
iajs-801	66	83	control	control	NOUN
iajs-801	66	84	10	10	NUM
iajs-801	66	85	950.000	950.000	NUM
iajs-801	66	86	±	±	NUM
iajs-801	66	87	104.881	104.881	NUM
iajs-801	66	88	s	s	NOUN
iajs-801	66	89	:	:	PUNCT
iajs-801	66	90	significant	significant	ADJ
iajs-801	66	91	ibn	ibn	PROPN
iajs-801	66	92	alhaitham	alhaitham	NOUN
iajs-801	67	1	j.	j.	PROPN
iajs-801	68	1	fo	fo	ADP
iajs-801	68	2	r	r	NOUN
iajs-801	68	3	pure	pure	ADJ
iajs-801	68	4	&	&	CCONJ
iajs-801	68	5	appl	appl	PROPN
iajs-801	68	6	.	.	PUNCT
iajs-801	69	1	sci	sci	PROPN
iajs-801	69	2	.	.	PROPN
iajs-801	70	1	vo	vo	INTJ
iajs-801	71	1	l.24	l.24	PROPN
iajs-801	71	2	(	(	PUNCT
iajs-801	71	3	1	1	NUM
iajs-801	71	4	)	)	PUNCT
iajs-801	71	5	2011	2011	NUM
iajs-801	71	6	fig.(1	fig.(1	NUM
iajs-801	71	7	):	):	PUNCT
iajs-801	71	8	the	the	DET
iajs-801	71	9	correlation	correlation	NOUN
iajs-801	71	10	relation	relation	NOUN
iajs-801	71	11	between	between	ADP
iajs-801	71	12	α1	α1	PROPN
iajs-801	71	13	–	–	PUNCT
iajs-801	71	14	antitrypsine	antitrypsine	NOUN
iajs-801	71	15	and	and	CCONJ
iajs-801	71	16	reduced	reduce	VERB
iajs-801	71	17	glutathione	glutathione	NOUN
iajs-801	71	18	for	for	ADP
iajs-801	71	19	dm	dm	PROPN
iajs-801	71	20	2	2	NUM
iajs-801	71	21	patints	patint	NOUN
iajs-801	71	22	and	and	CCONJ
iajs-801	71	23	healthy	healthy	ADJ
iajs-801	71	24	control	control	NOUN
iajs-801	71	25	.	.	PUNCT
iajs-801	72	1	2011	2011	NUM
iajs-801	72	2	)	)	PUNCT
iajs-801	72	3	1	1	NUM
iajs-801	72	4	(	(	PUNCT
iajs-801	72	5	24المجلد	24المجلد	NUM
iajs-801	72	6	مجلة	مجلة	VERB
iajs-801	72	7	ابن	ابن	PROPN
iajs-801	72	8	الھیثم	الھیثم	PROPN
iajs-801	72	9	للعلوم	للعلوم	PROPN
iajs-801	72	10	الصرفة	الصرفة	PROPN
iajs-801	72	11	والتطبیقیة	والتطبیقیة	PROPN
iajs-801	73	1	للمرضى	للمرضى	PROPN
iajs-801	73	2	العراقیین	العراقیین	PROPN
iajs-801	73	3	α1	α1	PROPN
iajs-801	73	4	–	–	PUNCT
iajs-801	73	5	antitrypsin	antitrypsin	NOUN
iajs-801	73	6	gshتقدیر	gshتقدیر	PROPN
iajs-801	73	7	الكلوتاثیون	الكلوتاثیون	PROPN
iajs-801	73	8	المختزل	المختزل	PROPN
iajs-801	73	9	المصابین	المصابین	PROPN
iajs-801	73	10	بداء	بداء	PROPN
iajs-801	73	11	السكري	السكري	PROPN
iajs-801	73	12	من	من	PRON
iajs-801	73	13	النوع	النوع	PROPN
iajs-801	73	14	الثاني	الثاني	PROPN
iajs-801	73	15	2010	2010	NUM
iajs-801	73	16	ایار	ایار	ADJ
iajs-801	73	17	9	9	NUM
iajs-801	73	18	:	:	PUNCT
iajs-801	73	19	استلم	استلم	PROPN
iajs-801	73	20	البحث	البحث	VERB
iajs-801	73	21	في	في	ADP
iajs-801	73	22	2010	2010	NUM
iajs-801	73	23	حزیران	حزیران	NOUN
iajs-801	73	24	30	30	NUM
iajs-801	73	25	:	:	PUNCT
iajs-801	73	26	قبل	قبل	NOUN
iajs-801	73	27	البحث	البحث	VERB
iajs-801	73	28	في	في	ADP
iajs-801	73	29	یحیى	یحیى	NOUN
iajs-801	73	30	یحیى	یحیى	NOUN
iajs-801	74	1	زكي	زكي	NOUN
iajs-801	74	2	فرید	فرید	PROPN
iajs-801	74	3	،	،	PROPN
iajs-801	74	4	أنوار	أنوار	PROPN
iajs-801	74	5	فاروق	فاروق	PROPN
iajs-801	74	6	مسلم	مسلم	PROPN
iajs-801	74	7	الطائي	الطائي	PROPN
iajs-801	74	8	*	*	PUNCT
iajs-801	74	9	وفاء	وفاء	NOUN
iajs-801	74	10	فاضل	فاضل	PROPN
iajs-801	74	11	الطائي	الطائي	PROPN
iajs-801	74	12	،	،	PROPN
iajs-801	74	13	جامعة	جامعة	PROPN
iajs-801	74	14	بغداد	بغداد	PROPN
iajs-801	74	15	،	،	PROPN
iajs-801	74	16	ابن	ابن	PROPN
iajs-801	74	17	الھیثم	الھیثم	PROPN
iajs-801	74	18	–	–	PUNCT
iajs-801	74	19	كلیة	كلیة	PROPN
iajs-801	74	20	التربیة	التربیة	NOUN
iajs-801	74	21	،	،	PROPN
iajs-801	75	1	قسم	قسم	PROPN
iajs-801	75	2	الكیمیاء	الكیمیاء	PROPN
iajs-801	75	3	ن	ن	PRON
iajs-801	75	4	جامعة	جامعة	PROPN
iajs-801	75	5	النھری	النھری	PROPN
iajs-801	75	6	،	،	PROPN
iajs-801	75	7	كلیة	كلیة	PROPN
iajs-801	75	8	الطب	الطب	PROPN
iajs-801	75	9	الخالصة	الخالصة	PROPN
iajs-801	75	10	ــزل	ــزل	NOUN
iajs-801	75	11	(	(	PUNCT
iajs-801	75	12	لدراسـة	لدراسـة	NOUN
iajs-801	75	13	مسـتویات	مسـتویات	VERB
iajs-801	75	14	اثیون	اثیون	NOUN
iajs-801	75	15	المخت	المخت	NOUN
iajs-801	75	16	فـي	فـي	NOUN
iajs-801	75	17	مصــل	مصــل	VERB
iajs-801	75	18	α1	α1	PROPN
iajs-801	75	19	–	–	PUNCT
iajs-801	75	20	antitrypsine	antitrypsine	VERB
iajs-801	75	21	بوصـفھم	بوصـفھم	ADJ
iajs-801	75	22	والمضـاد	والمضـاد	PROPN
iajs-801	75	23	للتـربین	للتـربین	PROPN
iajs-801	75	24	مــن	مــن	PROPN
iajs-801	75	25	gshالكلوـت	gshالكلوـت	PROPN
iajs-801	75	26	وع	وع	ADP
iajs-801	75	27	الثـاني	الثـاني	NOUN
iajs-801	75	28	ینعشـر	ینعشـر	NOUN
iajs-801	76	1	ن	ن	PRON
iajs-801	76	2	الـن	الـن	NOUN
iajs-801	76	3	داء	داء	ADV
iajs-801	76	4	السـكري	السـكري	PROPN
iajs-801	76	5	ـم	ـم	INTJ
iajs-801	76	6	ن	ن	PRON
iajs-801	76	7	االصـحاء	االصـحاء	NOUN
iajs-801	76	8	فضـال	فضـال	ADV
iajs-801	77	1	عــن	عــن	INTJ
iajs-801	77	2	مصـاباً	مصـاباً	NUM
iajs-801	77	3	ـب	ـب	PROPN
iajs-801	77	4	ي	ي	PROPN
iajs-801	77	5	ھــذه	ھــذه	PROPN
iajs-801	77	6	،	،	X
iajs-801	77	7	اذمجموعـة	اذمجموعـة	NOUN
iajs-801	77	8	سـیطرة	سـیطرة	PROPN
iajs-801	77	9	بوصـفھم	بوصـفھم	INTJ
iajs-801	77	10	عشـرة	عشـرة	PROPN
iajs-801	77	11	ـم	ـم	PRON
iajs-801	77	12	وجـد	وجـد	VERB
iajs-801	77	13	ـف	ـف	PRON
iajs-801	77	14	ــزل	ــزل	VERB
iajs-801	77	15	ــاثیون	ــاثیون	NOUN
iajs-801	77	16	المخت	المخت	PROPN
iajs-801	77	17	ــز	ــز	PROPN
iajs-801	77	18	لمســتوى	لمســتوى	PROPN
iajs-801	77	19	الكلوت	الكلوت	PROPN
iajs-801	77	20	ــة	ــة	PROPN
iajs-801	77	21	مــع	مــع	PROPN
iajs-801	77	22	االصــحاء	االصــحاء	PROPN
iajs-801	77	23	gshالدراسـة	gshالدراسـة	PROPN
iajs-801	77	24	نقصــان	نقصــان	PROPN
iajs-801	77	25	ممی	ممی	PROPN
iajs-801	77	26	ــاني	ــاني	AUX
iajs-801	77	27	مقارن	مقارن	VERB
iajs-801	77	28	.لمرضــى	.لمرضــى	NOUN
iajs-801	77	29	داء	داء	ADV
iajs-801	77	30	الســكري	الســكري	PROPN
iajs-801	77	31	مــن	مــن	PROPN
iajs-801	77	32	النــوع	النــوع	PROPN
iajs-801	77	33	الث	الث	PROPN
iajs-801	77	34	ع	ع	PROPN
iajs-801	77	35	α1	α1	PROPN
iajs-801	77	36	–	–	PUNCT
iajs-801	77	37	antitrypsineوفي	antitrypsineوفي	PROPN
iajs-801	77	38	الجانب	الجانب	NOUN
iajs-801	77	39	اآلخر	اآلخر	PROPN
iajs-801	77	40	لوحظت	لوحظت	PROPN
iajs-801	77	41	زیادة	زیادة	PROPN
iajs-801	77	42	ممیـزة	ممیـزة	VERB
iajs-801	78	1	لمسـتوى	لمسـتوى	PROPN
iajs-801	78	2	ك	ك	X
iajs-801	78	3	المرضـى	المرضـى	PROPN
iajs-801	78	4	بالمقارنـة	بالمقارنـة	PROPN
iajs-801	78	5	ـم	ـم	ADP
iajs-801	78	6	ن	ن	PRON
iajs-801	78	7	أألولـئ	أألولـئ	PROPN
iajs-801	78	8	نظـارھم	نظـارھم	NOUN
iajs-801	78	9	ـم	ـم	NOUN
iajs-801	78	10	.االصحاء	.االصحاء	ADP
iajs-801	78	11	وع	وع	ADP
iajs-801	78	12	الثـاني	الثـاني	NOUN
iajs-801	78	13	α1	α1	PROPN
iajs-801	78	14	–	–	PUNCT
iajs-801	78	15	antitrypsineلوحظت	antitrypsineلوحظت	VERB
iajs-801	78	16	العالقة	العالقة	PROPN
iajs-801	78	17	بین	بین	PROPN
iajs-801	79	1	ن	ن	PROPN
iajs-801	79	2	الـن	الـن	ADV
iajs-801	79	3	زل	زل	ADV
iajs-801	79	4	لمرضـى	لمرضـى	PROPN
iajs-801	79	5	داء	داء	PROPN
iajs-801	79	6	السـكري	السـكري	PROPN
iajs-801	79	7	ـم	ـم	PRON
iajs-801	79	8	-)و	-)و	PROPN
iajs-801	79	9	(	(	PUNCT
iajs-801	79	10	ve+)والكلوتاثیون	ve+)والكلوتاثیون	PROPN
iajs-801	79	11	المخـت	المخـت	PROPN
iajs-801	79	12	ve	ve	PROPN
iajs-801	79	13	)	)	PUNCT
iajs-801	79	14	لالصحاء	لالصحاء	PROPN
iajs-801	79	15	وكانت	وكانت	PROPN
iajs-801	79	16	قیمة(r	قیمة(r	PROPN
iajs-801	79	17	)	)	PUNCT
iajs-801	79	18	على	على	NOUN
iajs-801	79	19	التوالي	التوالي	NOUN
iajs-801	79	20	)	)	PUNCT
iajs-801	79	21	0,337-(و	0,337-(و	NUM
iajs-801	79	22	)	)	PUNCT
iajs-801	80	1	0,257(مساویة	0,257(مساویة	NUM
iajs-801	81	1	اـ	اـ	PROPN
iajs-801	81	2	.	.	PUNCT
iajs-801	82	1	اثیون	اثیون	PROPN
iajs-801	82	2	المختـزل	المختـزل	PROPN
iajs-801	82	3	ق	ق	NOUN
iajs-801	82	4	الجـذور	الجـذور	VERB
iajs-801	82	5	الحـرة	الحـرة	ADV
iajs-801	82	6	بنسـبة	بنسـبة	PROPN
iajs-801	82	7	gshوقد	gshوقد	PROPN
iajs-801	82	8	لوحظ	لوحظ	VERB
iajs-801	82	9	من	من	PRON
iajs-801	82	10	النتائج	النتائج	NOUN
iajs-801	82	11	ان	ان	ADV
iajs-801	82	12	اسـتھالك	اسـتھالك	ADJ
iajs-801	82	13	الكوـت	الكوـت	PROPN
iajs-801	82	14	الحـامي	الحـامي	PROPN
iajs-801	82	15	ضـد	ضـد	PROPN
iajs-801	82	16	االكسـدة	االكسـدة	PROPN
iajs-801	82	17	یؤكـد	یؤكـد	VERB
iajs-801	82	18	تخلـی	تخلـی	PROPN
iajs-801	82	19	.المصابین	.المصابین	PROPN
iajs-801	82	20	في	في	PROPN
iajs-801	82	21	مصل	مصل	PROPN
iajs-801	82	22	α1	α1	PROPN
iajs-801	82	23	–	–	PUNCT
iajs-801	82	24	antitrypsineي	antitrypsineي	VERB
iajs-801	82	25	عالیة	عالیة	PROPN
iajs-801	82	26	لدى	لدى	PROPN
iajs-801	82	27	المرضى	المرضى	PROPN
iajs-801	82	28	الذي	الذي	PROPN
iajs-801	82	29	یكون	یكون	VERB
iajs-801	82	30	مطابقاً	مطابقاً	NUM
iajs-801	82	31	للمستوى	للمستوى	NOUN
iajs-801	82	32	العال	العال	PROPN
iajs-801	82	33	،	،	PROPN
iajs-801	82	34	الكلوتاثایون	الكلوتاثایون	PROPN
iajs-801	82	35	،	،	PROPN
iajs-801	82	36	داء	داء	PROPN
iajs-801	83	1	السكري	السكري	AUX
iajs-801	83	2	النوع	النوع	PROPN
iajs-801	83	3	الثاني	الثاني	PROPN
iajs-801	83	4	α1مضاد	α1مضاد	NOUN
iajs-801	83	5	التربسین	التربسین	ADJ
iajs-801	83	6	نوع	نوع	NOUN
iajs-801	83	7	:	:	PUNCT
iajs-801	83	8	الكلمات	الكلمات	VERB
iajs-801	83	9	المفتاحیة	المفتاحیة	ADV